WO1999064616A2 - Polyunsaturated fatty acids in plants - Google Patents
Polyunsaturated fatty acids in plants Download PDFInfo
- Publication number
- WO1999064616A2 WO1999064616A2 PCT/US1999/013332 US9913332W WO9964616A2 WO 1999064616 A2 WO1999064616 A2 WO 1999064616A2 US 9913332 W US9913332 W US 9913332W WO 9964616 A2 WO9964616 A2 WO 9964616A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acid
- desaturase
- expression
- desaturases
- plants
- Prior art date
Links
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 title claims description 29
- 230000014509 gene expression Effects 0.000 claims abstract description 60
- 238000004519 manufacturing process Methods 0.000 claims abstract description 47
- 238000000034 method Methods 0.000 claims abstract description 34
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 47
- 229920001184 polypeptide Polymers 0.000 claims description 44
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 44
- 230000001105 regulatory effect Effects 0.000 claims description 15
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 12
- 230000002103 transcriptional effect Effects 0.000 claims description 12
- 239000002773 nucleotide Substances 0.000 claims description 6
- 125000003729 nucleotide group Chemical group 0.000 claims description 6
- 230000014621 translational initiation Effects 0.000 claims description 5
- 238000012258 culturing Methods 0.000 claims 1
- 230000001131 transforming effect Effects 0.000 claims 1
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 abstract description 52
- 235000014113 dietary fatty acids Nutrition 0.000 abstract description 45
- 229930195729 fatty acid Natural products 0.000 abstract description 45
- 239000000194 fatty acid Substances 0.000 abstract description 45
- 150000004665 fatty acids Chemical class 0.000 abstract description 45
- 235000021342 arachidonic acid Nutrition 0.000 abstract description 26
- 229940114079 arachidonic acid Drugs 0.000 abstract description 26
- 239000000203 mixture Substances 0.000 abstract description 24
- 230000009261 transgenic effect Effects 0.000 abstract description 22
- 108010037138 Linoleoyl-CoA Desaturase Proteins 0.000 abstract description 19
- 102100034544 Acyl-CoA 6-desaturase Human genes 0.000 abstract description 17
- 102100034542 Acyl-CoA (8-3)-desaturase Human genes 0.000 abstract description 13
- 108010073542 Delta-5 Fatty Acid Desaturase Proteins 0.000 abstract description 13
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract description 10
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 abstract description 7
- 235000020673 eicosapentaenoic acid Nutrition 0.000 abstract description 7
- 229960005135 eicosapentaenoic acid Drugs 0.000 abstract description 7
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 abstract description 7
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract description 6
- 230000004048 modification Effects 0.000 abstract description 6
- 238000012986 modification Methods 0.000 abstract description 6
- 150000007523 nucleic acids Chemical group 0.000 abstract description 6
- 239000000758 substrate Substances 0.000 abstract description 6
- 229940090949 docosahexaenoic acid Drugs 0.000 abstract description 5
- 150000004668 long chain fatty acids Chemical class 0.000 abstract description 5
- 108010087894 Fatty acid desaturases Proteins 0.000 abstract description 3
- 235000013399 edible fruits Nutrition 0.000 abstract description 3
- 229960002733 gamolenic acid Drugs 0.000 abstract description 3
- 229960004488 linolenic acid Drugs 0.000 abstract description 3
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 abstract description 2
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 abstract description 2
- 235000020664 gamma-linolenic acid Nutrition 0.000 abstract description 2
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 abstract 2
- 102000009114 Fatty acid desaturases Human genes 0.000 abstract 1
- 108700019146 Transgenes Proteins 0.000 abstract 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 abstract 1
- 239000010773 plant oil Substances 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 description 61
- 210000004027 cell Anatomy 0.000 description 54
- 108090000623 proteins and genes Proteins 0.000 description 47
- 230000000694 effects Effects 0.000 description 36
- 241000907999 Mortierella alpina Species 0.000 description 26
- 108020004414 DNA Proteins 0.000 description 22
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 21
- 235000020778 linoleic acid Nutrition 0.000 description 21
- 101710202365 Napin Proteins 0.000 description 20
- 239000002299 complementary DNA Substances 0.000 description 20
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 20
- 102000004190 Enzymes Human genes 0.000 description 17
- 108090000790 Enzymes Proteins 0.000 description 17
- 102000004169 proteins and genes Human genes 0.000 description 15
- 239000012634 fragment Substances 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 240000002791 Brassica napus Species 0.000 description 13
- 235000018102 proteins Nutrition 0.000 description 13
- 108091026890 Coding region Proteins 0.000 description 12
- 230000001965 increasing effect Effects 0.000 description 12
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 description 11
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 11
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 11
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 11
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 11
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 description 11
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 11
- 239000003550 marker Substances 0.000 description 11
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 11
- 235000021313 oleic acid Nutrition 0.000 description 11
- 239000005642 Oleic acid Substances 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- 238000003786 synthesis reaction Methods 0.000 description 10
- 230000009466 transformation Effects 0.000 description 10
- 239000013598 vector Substances 0.000 description 10
- OPGOLNDOMSBSCW-CLNHMMGSSA-N Fursultiamine hydrochloride Chemical compound Cl.C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N OPGOLNDOMSBSCW-CLNHMMGSSA-N 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 9
- JIWBIWFOSCKQMA-UHFFFAOYSA-N stearidonic acid Natural products CCC=CCC=CCC=CCC=CCCCCC(O)=O JIWBIWFOSCKQMA-UHFFFAOYSA-N 0.000 description 9
- 241000235575 Mortierella Species 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 241000219198 Brassica Species 0.000 description 7
- 235000011293 Brassica napus Nutrition 0.000 description 7
- 101710095856 Napin-3 Proteins 0.000 description 7
- 238000004817 gas chromatography Methods 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 108010033653 omega-3 fatty acid desaturase Proteins 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 238000012163 sequencing technique Methods 0.000 description 7
- 101100012567 Caenorhabditis elegans fat-1 gene Proteins 0.000 description 6
- 108020004705 Codon Proteins 0.000 description 6
- 108700026244 Open Reading Frames Proteins 0.000 description 6
- 108010011713 delta-15 desaturase Proteins 0.000 description 6
- 230000010354 integration Effects 0.000 description 6
- 230000037361 pathway Effects 0.000 description 6
- 235000011331 Brassica Nutrition 0.000 description 5
- 230000000692 anti-sense effect Effects 0.000 description 5
- 238000010367 cloning Methods 0.000 description 5
- 108020004999 messenger RNA Proteins 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 239000002243 precursor Substances 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 235000015112 vegetable and seed oil Nutrition 0.000 description 5
- UNSRRHDPHVZAHH-YOILPLPUSA-N (5Z,8Z,11Z)-icosatrienoic acid Chemical compound CCCCCCCC\C=C/C\C=C/C\C=C/CCCC(O)=O UNSRRHDPHVZAHH-YOILPLPUSA-N 0.000 description 4
- UNSRRHDPHVZAHH-UHFFFAOYSA-N 6beta,11alpha-Dihydroxy-3alpha,5alpha-cyclopregnan-20-on Natural products CCCCCCCCC=CCC=CCC=CCCCC(O)=O UNSRRHDPHVZAHH-UHFFFAOYSA-N 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 230000002018 overexpression Effects 0.000 description 4
- 230000003362 replicative effect Effects 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 230000010473 stable expression Effects 0.000 description 4
- 238000006467 substitution reaction Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- 241001072256 Boraginaceae Species 0.000 description 3
- 235000007689 Borago officinalis Nutrition 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000235395 Mucor Species 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 241000233671 Schizochytrium Species 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000006152 selective media Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- DFJAXEWDHVOILU-UHFFFAOYSA-N (5Z,9E)-5,9-Octadecadienoic acid Natural products CCCCCCCCC=CCCC=CCCCC(O)=O DFJAXEWDHVOILU-UHFFFAOYSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 241000589158 Agrobacterium Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000004594 DNA Polymerase I Human genes 0.000 description 2
- 108010017826 DNA Polymerase I Proteins 0.000 description 2
- 102100034543 Fatty acid desaturase 3 Human genes 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 241000219925 Oenothera Species 0.000 description 2
- 235000004496 Oenothera biennis Nutrition 0.000 description 2
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 241000206618 Porphyridium Species 0.000 description 2
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 2
- 240000001890 Ribes hudsonianum Species 0.000 description 2
- 235000001466 Ribes nigrum Nutrition 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- DFJAXEWDHVOILU-KWUOUXIESA-N Taxoleic acid Chemical compound CCCCCCCC\C=C/CC\C=C/CCCC(O)=O DFJAXEWDHVOILU-KWUOUXIESA-N 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 230000000368 destabilizing effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 235000021323 fish oil Nutrition 0.000 description 2
- 229940013317 fish oils Drugs 0.000 description 2
- 238000004508 fractional distillation Methods 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 235000019645 odor Nutrition 0.000 description 2
- 239000002751 oligonucleotide probe Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 150000003815 prostacyclins Chemical class 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000010153 self-pollination Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 230000010474 transient expression Effects 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- HXQHFNIKBKZGRP-URPRIDOGSA-N (5Z,9Z,12Z)-octadecatrienoic acid Chemical compound CCCCC\C=C/C\C=C/CC\C=C/CCCC(O)=O HXQHFNIKBKZGRP-URPRIDOGSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- 108020004491 Antisense DNA Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 241000722877 Borago Species 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 240000000385 Brassica napus var. napus Species 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 241001480517 Conidiobolus Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- 241001071905 Echium Species 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 241001480508 Entomophthora Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 101100288095 Klebsiella pneumoniae neo gene Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- -1 LA or GLA Chemical class 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001219224 Mortierella elongata Species 0.000 description 1
- 241000048020 Mortierella exigua Species 0.000 description 1
- 241000133355 Mortierella hygrophila Species 0.000 description 1
- 241000498617 Mucor javanicus Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 241001494715 Porphyridium purpureum Species 0.000 description 1
- 102100020754 Putative fatty acid desaturase 2-like protein FADS2B Human genes 0.000 description 1
- 241000233639 Pythium Species 0.000 description 1
- HXQHFNIKBKZGRP-UHFFFAOYSA-N Ranuncelin-saeure-methylester Natural products CCCCCC=CCC=CCCC=CCCCC(O)=O HXQHFNIKBKZGRP-UHFFFAOYSA-N 0.000 description 1
- 241000223252 Rhodotorula Species 0.000 description 1
- 241001249696 Senna alexandrina Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- AHANXAKGNAKFSK-PDBXOOCHSA-N all-cis-icosa-11,14,17-trienoic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCCCC(O)=O AHANXAKGNAKFSK-PDBXOOCHSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 235000020244 animal milk Nutrition 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000003816 antisense DNA Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000007942 carboxylates Chemical group 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical class C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- PRHHYVQTPBEDFE-UHFFFAOYSA-N eicosatrienoic acid Natural products CCCCCC=CCC=CCCCCC=CCCCC(O)=O PRHHYVQTPBEDFE-UHFFFAOYSA-N 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000013350 formula milk Nutrition 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000026045 iodination Effects 0.000 description 1
- 238000006192 iodination reaction Methods 0.000 description 1
- 150000002500 ions Chemical group 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000009343 monoculture Methods 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000002889 oleic acids Chemical class 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 238000004091 panning Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 235000020030 perry Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 238000007539 photo-oxidation reaction Methods 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 238000003751 purification from natural source Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000006257 total synthesis reaction Methods 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0083—Miscellaneous (1.14.99)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
- C12P7/6432—Eicosapentaenoic acids [EPA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
- C12P7/6434—Docosahexenoic acids [DHA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6472—Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
Definitions
- This invention relates to modulating levels of enzymes and/or e ⁇ fcyme components capable of altering the production of long chain polyunsaturated fatty acids (PUFAS) in a host plant.
- PUFAS long chain polyunsaturated fatty acids
- PUFAs polyunsaturated faity acids
- arachidonic acid the 3 fatty acids, exemplified by arachidonic acid, the o>9 fatty acids exemplified by Mead acid, and the ⁇ 6 fatty a ⁇ >ids, exemplified by eicosapentaenoic acid.
- PUFAs are important components of the plasma membrane of the cell, where ihey may be found in such forms as phospholipids.
- PUFAs also serve as precursors to other molecules of importance in human beings and animals, including the prostacyclins, leukoirienes and prostagla ⁇ dins. PUFAs are necessary for proper development, particularly in the developing infant brain, and for tissue formation and repair.
- GLA ga mu-linolenic acid
- SDA siearidonic acid
- DHA a number of sources exist for commercial production including a variety of marine organisms, oils obtained from cold water marine fish, and egg yolk fractions.
- ARA microorganisms including the genera M rtierellu, Entoniophthoru, Phylium and F rphyridi m can be used for commercial production.
- SDA SDA include the genera Trichodexmu and
- Cropland available for production of alternate oil-producing crops is subject l ⁇ competition from the steady expansion of human populations and the associated increased need for food production on the remaining arable land.
- Crops which do produce PUFAs, such as borage have not been adapted to commercial growth and may not perform well in monoculture. Growth of such crops is thus not economically competitive where more profitable and better established crops can be grown.
- Large scale fermentation of organisms such as Mortierella is also expensive. Natural animal tissues contain low amounts of ARA and are difficult to process. Microorganisms such as Porphy dium and Mortierella are difficult to cultivate on a commercial scale.
- Dietary supplements and pharmaceutical formulations containing PUFAs can retain the disadvantages of the PUFA source.
- Supplements such as fish oil capsules can contain low levels of the particular desired component and thus require large dosages.
- High dosages result in ingestion of high levels of undesired components, including contaminants.
- Care must be taken in providing fatty acid supplements, as overaddition may result in suppression of endogenous bi synthetic pathways and l ad to competition with other necessary fatty acids in various lipid fractions in vivo, leading to undesirable results.
- Eskimos having a diet high in ⁇ 3 fatty acids have an increased tendency to bleed (U.S. Pat. No. 4,874,603).
- Unpleasant tastes and odors of the supplements can make such regimens undesirable, and may inhibit compliance by the patient.
- LA, 18:2 ⁇ 9. 12 is produced from oleic acid (18; I ⁇ 9) by a ⁇ 12-desaturase.
- GLA 18:3 ⁇ 6. 9. 12
- linoleic acid LA, 18:2 ⁇ 9, 12
- ARA 20:4 ⁇ 5.
- 8. 1 1. 14 production from DGLA (20:3 ⁇ 8, 1 1 , 14) is catalyzed by a ⁇ 5 -desaturase.
- animals cannot desaturate beyond the ⁇ 9 position and therefore cannot convert oleic acid ( 18:1 ⁇ 9) into linoleic acid (1 :2
- ⁇ -Iinolenic acid (ALA, 18:3 ⁇ 9, 12, 15) cannot be synthesized by mammals.
- the major poly-unsaturatcd fatty acids of animals therefore arc either derived from diet and or from desaturation and i elongation of linoleic acid ( 18:2 ⁇ 9, 12) or oc-linolenic acid (18:3 ⁇ 9, 12, 15).
- Poly-unsaturatcd fatty acids are considered to be useful for nutritional, pharmaceutical, industrial, and other purposes.
- An expansive supply of polyunsaturated fatty acids from natural sources and from chemical synthesis are not sufficient for commercial needs. Therefore Lt is of interest to obtain genetic material involved in PUFA biosynthesis from species that naturally produce these fatty acids and to express the isolated material alone or in combination in a hctcr ⁇ log ⁇ us system which can be manipulated to allow production of commercial quantities of PUFAS.
- Novel compositions and methods are provided for preparation of polyunsaturated long chain fatty acids and desaturases in plants and plant cells.
- the methods involve growing a host plant cell of interest transformed with an expression cassette functional in a hose plant cell, the expression casse'te comprising a cranscriptional and translational initiation regulatory region, joined in reading frame 5' to a DNA sequence encoding a desaturase polypeptide capable of modulating the production of PUFAs.
- Expression of the desaturase polypeptide provides for an alteration in the PUFA profile of host plant cells as a result of altered concentrations of enzymes involved in PUFA biosynthesis.
- Of particular interest is the selective control of PUFA production in plant tissues and/or plant parts such as leaves, roots, fruits and seeds.
- the invention finds use for example in the large scale production of DHA, Mead Acid EPA, ARA, Stearidonic acid and GLA and for modification of the fatty acid profile of edible plant tissues and/or plant parts.
- Figure I shows possible pathways for the synthesis of Mead acid (20:3 ⁇ 5, 8, 1 1), arachidonic acid (20:4 ⁇ 5, 8, 1 1, 14) and stearidonic acid ( 18:4 ⁇ 6, 9. 12. 15) from palmitic acid (C ⁇ ) from a variety of organisms, including algae,
- PUFAs can serve as precursors to other molecules important for humans and other animals, including prostacyclins, lcukotrienes, and prostagla ⁇ dins, some of which are shown.
- Figure 2 shows possible pathways for production of PUFAs in addition to ARA, including taxoleic acid and pinolenic, again compiled from a variety of organisms.
- SEQ ID NO: I shows DNA sequence from a Schizochytrium clone with homology to both 12 and ⁇ 15 desaturases.
- SEQ ID NO 2 shows peptide sequence from a Schizochytrium clone with homology to both ⁇ 12 and ⁇ 15 desaturases.
- ⁇ 5-Desaturase is an enzyme which introduces a double bond between carbons 5 and 6 from the carboxyl end of a fatty acid molecule.
- ⁇ 6-Desaturase is an enzyme which introduces a double bond between carbons 6 and 7 from the carboxyl end of a fatty acid molecule.
- ⁇ 9-De_aturase ⁇ 9-desaturase is an enzyme which introduces a double bond between carbons 9 and 10 from the carboxyl end of a tatty acid molecule.
- ⁇ I2-Dcsatura&e is an enzyme which introduces a double bond between carbons 12 and 13 from the carboxyl end of a fatty acid molecule.
- Fatty acids are a class of compounds containing a long hydrocarbon chain and a terminal carboxylate group. Fatty acids include the following:
- the present invention is directed (o novel DNA sequences, DNA constructs, methods and compositions are provided which permit modification of the poly-unsaturated long chain fatty acid content of plane cells.
- Plant cells are transformed with an expression cassette comprising a
- DNA encoding a polypeptide capable of increasing the amount of one or more PUFA in a plant cell may be prepared which provide for integration of the expression cassette into the genome of a host cell.
- Host cells are manipulated to express a sense or antisense DNA encoding a polypcptidc(s) that has desaturase activity.
- desaturase is intended a polypeptide which can desaturate one or more fatty acids to produce a mono- or poly-unsaturated fatty acid or precursor thereof of interest.
- polypeptide is meant any chain of amino acids, regardless of length or post-translational modification, for example, glycosylatio ⁇ or phosphorylation.
- the substratc(s) for the expressed enzyme may be produced by the host cell or may be exogenously supplied.
- the transformed DNA is operably associated with transcriptional and translational initiation and termination regulatory regions thai are functional in the host cell.
- Constructs comprising the gene to be expressed can provide for integration into the genome of the host cell or can autonomously replicate in the host cell.
- the expression cassettes generally used include a cassette which provides for ⁇ 12 desaturase activity, particularly in a host cell which produces or can take up oleic acid.
- the expression cassettes generally used include a cassette which provides for ⁇ l 5 or ⁇ 3 desaturase activity, particularly in a host cell which produces or eu ⁇ take up LA.
- the expression cassettes generally used include a cassette which provides for ⁇ 6 desaturase activity, particularly in a host cell which produces or can take up LA or ALA, respectively.
- Production of ⁇ 6-iype unsaturated fatty acids, such as LA or GLA is favored in a plant capable of producing ALA by inhibiting the activity of a ⁇ 15 or ⁇ 3 type desaturase; this is accomplished by providing an expression cassette for an ami sense ⁇ 15 or »3 transcript, or by disrupting a ⁇ I5 or ⁇ >3 desaturase gene.
- LA or ALA is favored in a plant having ⁇ 6 desaturase activity by providing an expression cassette for an an ti sense ⁇ 6 transcript, or by disrupting a ⁇ 6 desaturase gene
- Production of oleic acid likewise is favored in a plant having ⁇ l 2 desaturase activity by providing an expression cassette for an antisense ⁇ 12 transcript, or by disrupting a ⁇ l 2 desaturase gene.
- the expression cassette generally used provides for ⁇ 5 desaturase activity, particularly in a ho.st cull which produces or can take up DCiLA. Production of ⁇ 6- type unsaturated fatty icids.
- ARA is favored in a plant capable of producing ALA by inhibiting the activity of a ⁇ 15 or ⁇ 3 type desaturase; this is accomplished by providing an expression cassette for an antisense ⁇ 15 or ⁇ 3 transcript, or by disrupting a ⁇ 15 or ⁇ 3 desaturase gene.
- Transgenic plant production of PUFAs offers several advantages over purification from natural sources such as fish or plants.
- Production of fatty acids from recombinant plants provides the ability to alter the naturally occurring plant fatty acid profile by providing new synthetic pathways in the host or by suppressing undesired pathways, thereby increasing levels of desired PUFAs, or conjugated forms thereof, and decreasing levels of undesired PUFAs.
- Production of fatty acids in transgenic plants also offers the advantage that expression of desaturase genes in particular tissues and/or plant parts means that greatly increased levels of desired PUFAs in those tissues ⁇ nd/or parts can be achieved, making recovery from those tissues more economical
- the desired PUFAs can be expressed in seed; methods of isolating seed oils are well established.
- seed oil components can be manipulated through expression of desaturase genes, either alone or in combination with other genes such as elongate., to provide seed oils having a particular PUFA profile in concentrated t ⁇ rm
- the concentrated seed oils then can be added 10 animal milks and/or synthetic or semi-synthetic milks to serve as infant formulas where human nursing is impossible or undesired, or in cases of malnourishmenl or disease in both adults and infants.
- LA to GLA of ALA to SDA
- oleic acid to LA or of LA to ALA, which includes enzymes which desaturate at the ⁇ 6, ⁇ 9, ⁇ 12, ⁇ 15 or ⁇ 3 positions.
- a specific polypeptide having desaturase activity include the pH optimum of the polypeptide, whether the polypeptide is a rate limiting enzyme or a component thereof, whether the desaturase used is essential for synthesis of a desired poly-unsaturated fatty acid, and/or co-factors required by the polypeptide.
- the expressed polypeptide preferably has parameters compatible with the biochemical environment of its location in the host cell. For example, the polypeptide may have to compete for substrate with other en/.ymes in the host cell. Analyses of the K-, and specific activity of the polypeptide in question therefore are considered in determining the suitability of a given polypeptide for modifying PUFA production in a given host cell.
- the polypeptide used in a particular situation therefore is one which can function under the conditions present in the intended host cell but otherwise can be any polypeptide having desaturase activity which has the desired characteristic of being capable of modifying the relative production of a desired PUFA.
- a scheme for the synthesis of arachidonic acid (20:4 ⁇ 5. 8, 11, 14) from palmitic acid (C ⁇ 6 ) is shown in Figure 1.
- a key enzyme in this pathway is a ⁇ 5-desaturase which converts DH- ⁇ -linolenic acid (DGLA, eicosatrienoic acid) to ARA.
- Conversion of -linolentc acid (ALA) to stearidonic acid by a ⁇ 6-desaturase is also shown.
- PUFAs in addition to ARA including EPA and DHA is shown in Figure 1.
- a key enzyme in the synthesis of arachidonic acid (20:4 ⁇ 5, 8, 11, 14) from stearic acid (C l ) is a ⁇ 6-des_turas- which converts the linoleic acid into ⁇ - linolenic acid.
- Conversion of ⁇ -li ⁇ olcnic acid (ALA) to stearidonic acid by a ⁇ 6- desaturase also is shown.
- the DNA sequence used encodes a polypeptide having ⁇ 5 desaturase activity.
- this can be coupled with an expression cassette which provides for production of a polypeptide having ⁇ 6 desaturase activity and, optionally, a transcription cassette providing for production of antisense sequences to a ⁇ 15 transcription product.
- an expression cassette which provides for production of a polypeptide having ⁇ 6 desaturase activity
- a transcription cassette providing for production of antisense sequences to a ⁇ 15 transcription product.
- the choice of combination of cassettes used depends in part on the PUFA profile of the host cell.
- sources of polypeptides having desaturase activity and oligo ⁇ ucleotides encoding such polypeptides are organisms which produce a desired polyunsaturated fatty acid.
- microorganisms having an ability to produce ARA can be used as a source of A5-desatura.se genes; microorganisms which GLA or SDA can be used as a source of ⁇ 6-desaturase and or ⁇ l 2- desarurase genes.
- Such microorganisms include, for example, those belonging to the genera Mortierella.
- Mortierella elongata Mortierella exigua, Mortierella hygrophila, Mortierella rumanniuna, var. angulispora, and Mortierella alptna.
- Mucor Within the genus Mucor, of particular interest are Mucor circinell ⁇ ulex and Mucor javanicus.
- DKAs encoding desired desaturases can be identified in a variety of ways.
- a source of the desired desaturase for example gc ⁇ omic or cDNA libraries from Mortierella. is screened with detectable enzymatically- or chemically-synthesized probes, which can be made from DNA, RNA. ' or hon- naturally occurring nucleotides, or mixtures thereof.
- Probes may be enzymatically synthesized from DNAs of known desamrases for normal or reduced-stringency hybridization methods.
- Oligonucleotide probes also can be used to screen sources and can be based on sequences ⁇ f known desaturases, including sequences conserved among known desaturases, or on peptide sequences obtained from the desired purified protein. Oligonucleotide probes based on amino acid sequences can be degenerate to encompass the degeneracy of the genetic code, or can be biased in favor of the preferred codons of the source organism. Oligomicleotides also can be used as primers for PCR from reverse transcribed mRNA from a known or suspected source; the PCR product can be the full length cDNA or can be used to generate a probe to obtain the desired full length cDNA.
- a desired protein can be entirely sequenced and total synthesis of a DNA encoding that polypeptide performed.
- the desired genomic or cDNA Once the desired genomic or cDNA has been isolated, it can be sequenced by known methods. It is recognized in the art that such methods are subject to errors, such that multiple sequencing of the same region is routine and is still expected to lead to measurable rates of mistakes in the resulting deduced sequence, particularly in regions having repeated domains, extensive secondary structure, or unusual base compositions, such as regions with high GC base content. When discrepancies arise, resequencing can be done and can employ special methods.
- Special methods can include altering sequencing conditions by using: different temperatures; different enzymes; proteins which alter the ability of oligonucleotides to form higher order structures; altered nucleotid s such as ITP or methylated dGTP; different gel compositions, for example adding formamide; different primers or primers located at different distances from the problem region; r different templates such as single stranded DNAs. Sequencing of mRNA can also be employed.
- some or all of the coding sequence for the polypeptide having desaturase activity is from a natural source. In some situations, however, it is desirable to modify all or a portion of the codons, for example, to enhance expression, by employing host preferred codons. Host preferred codons can be determined from the codons of highest frequency in the proteins expressed in the largest amount in a particular host species of interest. Thus, the coding sequence for a polypeptide having desaturase activity can be synthesized in whole or in pan.
- All or portions of the DNA also can be synthesized to remove any destabilizing sequences or regions of secondary nestture which would be present in the transcribed mRNA. All or portions of the DNA also can be synthesized to alter the base composition to one more preferable in the desired host cell. Methods for synthesizing sequences and bringing sequences together are well established in the literature. In mutagenesis and selection, site-directed mutagenesis, or other means can be employed to obtain mutations of naturally occurring desaturase genes to produce a polypeptide having desaturase activity in vivo with more desirable physical and kinetic parameters for function in the host cell, such as a longer half- life or a higher rate of production of a desired polyunsaturated fatty acid.
- Desirable cDNAs have less than 60% A+T composition, preferably less than 50% A+T composition. On a localized scale of a sliding window of 20 base pairs, it is preferable that there are no localized regions of the cDNA with greater than 75% A+T composition; with a window of 60 base pairs, it is preferable that there are no localized regions of the cDNA with greater than 60%, more preferably no localized regions with greater than 55% A+T composition.
- Mortierella alpina ⁇ 5-desaturase Of particular interest are the Mortierella alpina ⁇ 5-desaturase, ⁇ 6- desaturase, ⁇ l 2-desaturase and ⁇ 15 desaturase.
- the gene encoding the Mortierella alpina ⁇ 5-dcsaturase can be expressed in transgenic plants to effect greater synthesis of ARA from DGLA
- the gene encoding the Mortierella alpina ⁇ 6-desaturase can be expressed in transgenic plants or animals to effect greater synthesis of GLA from linoleic acid or of stearidonic acid (SDA) from ALA.
- SDA stearidonic acid
- Other DNAs which are substantially identical in sequence to the Monierelia alpina ⁇ 6-desaturase DNA, or which encode polypeptides which are substantially identical in sequence to the Mortierella alpina ⁇ 6-desa ⁇ urase polypeptide also can be used.
- the gene encoding the Mortierella alpina ⁇ 12-desaturase can be expressed in transgenic plants to effect greater synthesis of LA from oleic acid.
- substantially identical in sequence is intended an amino acid sequence or nucleic acid sequence exhibiting in order of increasing preference at least 60%.
- the length of comparison sequences generally is at least 16 amino acids, preferably at least 20 amino acids, or most preferably 35 amino acids.
- the length of comparison sequences generally is at least 50 nucleotides, preferably at least 60 nucleotides, and more preferably at least 75 nucleotides. and most preferably, 1 10 nucleotides.
- Homology typically is measured using sequence analysis software, for example, the Sequence Analysis software package of the Genetics Computer Group, University of Wisconsin Biotechnology Center, 1710 University Avenue, Madison, Wisconsin 53705, MEGAlig ⁇
- Conservative substitutions typically include substitutions within the following groups: glycine and alanine; valine, isolcucine and leucine; aspa ⁇ ic acid, glutamic acid, asparagine, and glutamine; serine and threonine; lysine and arginine; and phenylalanine and tyrosine.
- the DNA encoding a desaturase polypeptide is placed in a vector capable of replication in a host cell, or is propagated in vitro by means of techniques such as PCR or long PCR.
- Replicating vectors can include plasmids, phage, viruses, cosmids and the like.
- Desirable vectors include those useful for mutagenesis of the gene of interest or for expression of the gene of interest in host cells.
- the technique of long PCR has made in vitro propagation of targe constructs possible, so that modifications to the gene of interest, such as mutagenesis or addition of expression signals, and propagation of the resulting constructs can occur entirely in vitro without the use of a replicating vector or a host cell.
- a desaturase polypeptide For expression of a desaturase polypeptide, functional transcriptional and translational initiation and termination regions are operably linked to the DNA encoding the desaturase polypeptide.
- Transcriptional and translational initiation and termination regions are derived from a variety of nonexclusive sources, including the DNA to be expressed, genes known or suspected to be capable of expression in the desired system, expression vectors, chemical synthesis, or from an endogenous locus in a host cell.
- Expression in a plant tissue and/or plant pare presents certain efficiencies, particularly where the tissue or part is one which is easily harvested, such as seed, leaves, fruits, flowers, roots, etc. Expression can be targeted to that location within the plant by using specific regulatory sequences, such as those of USPN 5,463.174, USPN 4,943,674.
- the expressed protein can be an enzyme which produces a product which may be incorporated, either directly or upon further modifications, into a fluid fraction from the host plant.
- expression of desaturase genes, or antisense desaturase transcripts can alter the levels of specific PUFAs, or derivatives thereof, found in plant parts and or plant tissues.
- the ⁇ 5-desaturasc polypeptide coding region is expressed either by itself or with other genes, in order to produce tissues and/or plant pans containing higher proportions of desired
- the termination region can be derived from the 3' region of the gene from which the initiation region was obtained or from a different gene.
- a large number of term i nut ion regions are known to and have been found to be satisfactory in a variety of hosts from the same and different genera and species.
- the termination region usually is selected more as a matter of convenience rather than because of any particular property.
- the choice of a host cell is influenced in pan by the desired PUFA profile of the transgenic cell, and the native profile of the host cell.
- the DNA sequence used encodes a polypeptide having ⁇ I2 desaturase activity
- the DNA sequence used encodes a polypeptide having ⁇ 6 desaturase activity.
- Use of a host cell which expresses ⁇ 12 desaturase activity and lacks or is depleted in ⁇ 15 desaturase activity can be used with an expression cassette which provides for overexpression of ⁇ 6 desaturase alone generally is sufficient to provide for enhanced GLA production in the transgenic cell.
- ⁇ 9 desaturase activity expression of both a ⁇ l 2- and a ⁇ 6-desarurase can provide for enhanced GLA production.
- expression of ⁇ 6 desaturase activity is coupled with expression of ⁇ 12 desaturase activity, it is desirable that the host cell naturally have, or be mutated to have, low ⁇ 15 desaturase activity.
- a host cell for ⁇ 6 desaturase expression may have, or be mutated to have, high ⁇ l 2 desaturase activity.
- Transient expression in a host cell can be accomplished in a transient or stable fashion.
- Transient expression can occur from introduced constructs which contain expression signals functional in the host cell, but which constructs do not replicate and rarely integrate in the host cell, or where the host cell is not proliferating.
- Transient expression also can be accomplished by inducing the activity of a regulatable promoter operably linked to the gene of interest, although such inducible systems frequently exhibit a low basal level of expression.
- Stable expression can be achieved by introduction of a construct that can integrate into the host genome or that autonomously replicates in the host cell.
- Stable expression of the gene of interest can be selected for through the use of a selectable marker located on or transfected with the expression construct, followed by selection for cells expressing the marker.
- constructs When stable expression results from integration, integration of constructs can occur randomly within the host genome or can be targeted through the use of constructs containing regions of homology with the host genome sufficient to target recombination with the host locus. Where constructs are targeted to an endogenous locus, all or some of the transcript i onal and translational regulatory regions can be provided by the endogenous locus.
- the desaturase polypeptide in the source plant When increased expression of the desaturase polypeptide in the source plant is desired, several methods can be employed. Additional genes encoding the desaturase polypeptide can be introduced into the host organism. Expression from the native desaturase locus also can be increased through homologous recombination, for example by inserting a stronger promoter into the host genome to cause increased expression, by removing destabilizing sequences from either the mRNA or the encoded protein by deleting that information from the host genome, or by adding stabilizing sequences to the mRNA (see USPN 4,910, 1 1 and USPN
- introduced genes can be propagated in the host cell through use of replicating vectors or by integration into the host genome. Where two or more genes are expressed from separate replicating vectors, it is desirable that each vector has a different means of replication.
- Each introduced construct, whether integrated or not. should have a different means of selection and should lack homology to the other constructs to maintain stable expression and prevent reassortme ⁇ i of elements among constructs. Judicious choices of regulatory regions, selection means and method of propagation of the introduced construct can be experimentally determined so that all introduced genes are expressed at the necessary levels to provide for synthesis of the desired products.
- Constructs comprising the gene of interest may be introduced into a host cell by standard techniques. These techniques include transfection, infection, holistic impact, electroporaiion, microinjection. scraping, or any other method which introduces the gene of interest into the host cell (see USPN 4,743,548, USPN 4,795.855, USPN 5,068.193, USPN 5, 188,958, USPN 5.463,174, USPN 5,565,346 and USPN 5,565,347).
- a host cell which has been manipulated by any method to take up a DNA sequence or construct will be referred to as "transformed” or "rccombinant” herein.
- the subject host will have at least have one copy of the expression construct and may have two or more, depending upon whether the gene is integrated into the genome, amplified, or is present on an extrachromosomal element having multiple copy numbers.
- the transformed host cell can be identified by selection for a marker contained on the introduced construct.
- a separate marker construct may be introduced with the desired construct, as many transformation techniques introduce many DNA molecules into host cells.
- transformed hosts are selected for their ability to grow on selective media. Selective media may incorporate an antibiotic or lack a factor necessary for growth of the untransformed host, such as a nutrient or growth factor.
- An introduced marker gene therefor may confer antibiotic resistance, or encode an essential growth factor or enzyme, and permit growth on selective media when expressed in the transformed host cell. Desirably, resistance to kanamycin and the amino glycoside G 18 are of interest (see USPN 5,034,322). Selection of a transformed host can also occur when the expressed marker protein can be detected, either directly or indirectly.
- the marker protein may be expressed alone or as a fusion to another protein.
- the marker protein can be detected by its enzymatic activity; for example ⁇ gaiaclosidase can convert the substraie X-gal to a colored product, and lucif ⁇ rase can convert luciferin to a light-emitting product.
- the marker protein can be detected by its light-producing or modifying characteristics; for example, the green fluorescent protein c ⁇ equorea ictoria fluoresces when illuminated with blue light.
- Antibodies can be used to detect the marker protein or a molecular tag on, for example, a protein of interest.
- Cells expressing the marker protein or tag can be selected, for example, visually, or by techniques such as FACS or panning using antibodies.
- the PUFAs produced using the subject methods and compositions may be found in the host plant tissue and/or plant part as free fatty acids or in conjugated forms such as acylglycerols, ph ⁇ spholipids, sulfolipids or glycolipids. and may be extracted from the host cell through a variety of means well-known in the art.
- Such means may include extraction wiih organic solvents, sonication, supercritical fluid extraction using for example carbon dioxide, and physical means such as presses, or combinations thereo
- extraction with hexane or methanol and chloroform.
- the aqueous layer can be acidified to protonate negatively charged moieties and thereby increase partitioning of desired products into the organic layer.
- the organic solvents can be removed by evaporation under a stream of nitrogen.
- conjugated forms of fatty acids are cleaved with potassium hydroxide.
- Probes based on the DNAs of the present invention may find use in methods for isolating related molecules or in methods to detect organisms expressing desaturases.
- the DNAs or oligonuclcotides need to be detectable. This is usually accomplished by attaching a label either at an internal site, for example via incorporation of a modified residue, or at the 5' or 3' terminus.
- Such labels can be directly detectable, can bind to a secondary molecule that is detectably labeled, or can bind to an unlabelled secondary molecule and a detectably labeled tertiary molecule: this process can be extended as long as is practical to achieve a satisfactorily detectable signal without unacceptable levels of background signal.
- Secondary, tertiary, or bridging systems can include use of antibodies directed against any other molecule, including labels or other antibodies, or can involve any molecules which bind to each other, for example a biotin-streptavidin avidin system.
- Detectable labels typically include radioactive isotopes, molecules which chemically or enzymatically produce or alter light, enzymes which produce detectable reaction products, magnetic molecules, fluorescent molecules or molecules whose fluorescence or light-emitting characteristics change upon binding. Examples of labelling methods can be found in USPN 5,01 1 ,770.
- the binding of target molecules can be directly detected by measuring the change in heat of solution on binding of probe to target via isothermal lit ration caiorimetry, or by coating rhe probe or target on a surface and detecting the change in scattering of light from the surface produced by binding of target or probe, respectively, as may be done with the BLAcore system.
- the D15/ ⁇ -3 activity of Brassica napus can be increased by the expression of an ⁇ -3 desaturase from C. elegans.
- the fat-1 cDNA clone (Gcnbank accession l li807; Spychalla, J. P., Kinney, A. J., and Browse, J. 1997 P.N.A.S. 94, 1 142-
- the fat-1 cDNA was modified by PCR to introduce cloning sites using the following primers:
- oligonucleotides were .'igated into Sall/XhoI-digested pCGN7770 to produce pCGN861 .
- These oligos encode BamHI, Notl, Hindlll, and Pstl restriction sites.
- pCGN8619 contains the oligos oriented such that the Pstl site is closest to the napin 5' regulatory region. A fragment containing the napin 5' regulatory region, polylinker, and napin 3' region was removed from pCGN8619 by digestion with Asp7181.
- the fragment was blunt-ended by filling in the 5' overhangs with Klenow fragment then ligaied into pCGN5 l 39 that had been digested with Asp7l8I and Hindlll and blunt-ended by filling in the 5' overhangs with Klenow fragment.
- a plasmid containing the insert oriented so that the napin promoter was closest to the blunted A.sp7l 81 site of pCGN5139 and the napin 3' was closest to the blunted Hindlll site was subjected to sequence analysis to confirm both the insert orientation and the integrity of cloning junctions.
- the resulting plasmid was designated pCGN8623.
- elegans ⁇ -3 desaturase can be combined with D6- and D 12-desaturases from Mortierella alpina.
- PCGN5563-transformed plants may be crossed with pCGN5 44- transformed plants expressing the D6-and D 12-desarurascs.
- the resulting FI seeds can be analyzed for stearidonic acid content and selected FI plants can be used for self-pollination to produce F2 seed, or as donors for production of dihaploids, or additional crosses.
- An alternative method to combine the fat-1 cDNA with M. alpina D6 and Dl2 desaturases is to combine them on one T-DNA for transformation.
- the fat-1 coding region from pC ⁇ N5562 can be cut out as a Pstl Notl fragment and inserted into Pstl Notl digested pCGN8619.
- the transcriptional unit consisting of the napin 5" regulatory region, the fat- 1 coding region, and the napin 3'-regulatory region can be cut out as a Sse83871 fragment and inserted into pCGN5544 cut with Sse8387I.
- the resulting plasmid would contain three napin transcriptional units containing the C. elegans ⁇ -3 desaturase, M. alpina D6 desaturase, and M. alpina D) desaturase, all oriented in the same direction as the 35S/nptll ⁇ ml transcriptional unit used for selection of transformed tissue.
- the D15-desaturase activity of Brassica napus can be increased by over- expression of the D15-desaturase cDNA clone.
- a B. napus D 15-des ⁇ turase cDNA clone was obtained by PCR amplification of first-strand cDNA derived from B. napus cv. 212 R6. The primers were based on published sequence: Genbank # L I41 Arondel et al, 1992 Science 258: 1353-1355.
- the PCR product was subcloned into pAMPl (GIBCOBRL) using the CloneAmp system (GIBCOBRL) to create pCGN5520.
- the sequence was verified by sequencing of both strands to be sure that the open reading frame remained intact.
- the D15-desacurase coding region was cut out of pCGN5520 as a BamHI/Sall fragment and inserted between the Bglll and Xhol sites of the pCGN7770, to create pCGN5557.
- napus D15-desaturase, and napin 3'- regulatory region was inserted into the Pstl site of the binary vector, pCGN5138 to produce pCGN5558.
- pCGN5558 was introduced into Brassica napus via Agrohacterium- tdx&ied transformation.
- the D15-desaturase can be combined with D6- and D12-desaturases from Mortierella alpina.
- PCGN5558-transformed plants may be crossed with pCGN5544-transformed plants expressing the D6 and 12-desaturases.
- the resulting FI seeds can be analyzed for stearidonic acid content and selected FI planes can be used for self-pollination to produce F2 seed, or d donors for production of dihapioids. or additional crosses.
- An alternative method to combine the B. napus Dl5-desaturase with M. alpina D6 and D 12 desaturases is to combine them on one T-DN A for transformation.
- the transcription cassette consisting of the napin 5'-regulatory region, the D 15-desaturasc coding region, and the napin 3'-regulatory region can be cut out of pCGN5557 as a Swal fragment and inserted into Swal-digested ⁇ CGN5544.
- the resulting plasmid would contain three napin transcriptional units containing the M. alpina D6 desatura.se, the B. napus Dl5-dcsaturase, and the M. alpina D1 desaturase, all oriented in the same direction as the 35S/n ⁇ t!I/tmi transcriptional unit used for selection of transformed tissue.
- Ma29 is a putative M. alpina D5 desaturase as determined by sequence homology. This experiment was designed to determine whether leaves expressing Ma29 (as determined by Northern) were able to convert exogenously applied DGLA (20:3) to ARA (20:4).
- the Ma29 desaturase cDNA was modified by PCR to introduce convenient restriction sites for cloning. The desaturase coding region has been inserted into a d35 cassette under the control of the double 35S promoter for expression in Brassica leaves (pCGN5525) following standard protocols (see USPN 5,424,200 and USPN 5.106,739). Transgenic Brassica plants containing pCGN5525 were generaied following standard protocols (see USPN 5,188,958 and USPN 5,463.174).
- LP004 is & low-linolenic Brassica variety. Leaves of each were selected for one of three treatments: water, GLA or DGLA.
- GLA and DGLA were purchased as sodium salts from NuChek Prep and dissolved in water at 1 mg/ml. Aliquots were capped under N_ and stored at -70 degrees C. Leaves were treated by applying a 50 ⁇ i drop to the upper surface and gently spreading with a gloved finger to cover the entire surface. Applications were made approximately 30 minutes before the end of the light cycle to minimize any photo- oxidation of the applied fairy acids. After 6 days of treatment one leaf from each treatment was harvested and cut in half through the mid rib. One half was washed with water to attempt to remove unincorporated fatty acid. Leaf samples were lyophilized overnight, and fatty acid composition determined by gas chromatography (GC). The results are shown in Table 1.
- Leaves treated with GLA contained from 1.56 to 2.4 wt% GLA.
- the fatty acid analysis showed that the lipid composition of control and transgenic leaves was essentially the same.
- Leaves of control plants treated with DGLA contained 1.2- 1.9 w% DGLA and background amounts of ARA (.26-.27 wt%).
- Transgenic leaves contained only .2- 7 wt% DGLA. but levels of ARA were increased (.74- 1.1 wt%) indicating that the DGLA was convened to ARA in these leaves.
- the purpose of this experiment was to determine whether a construct with the seed specific napin promoter would enable expression in seed.
- the a29 cDNA was modified by PCR to introduce Xhol cloning sites upstream and downstream of the start and stop codons, respectively, using the following primers: .
- PCR product was subcloned into pAMPl (GIBCOBRL) using the CloneAmp system (GIBCOBRL) to create pCGN5522 and the ⁇ 5 desaturase sequence was verified by sequencing of both strands.
- the Ma29 coding region was cut out of pCGN5522 as an Xhol fragment and inserted into the Sail site of the napin expression cassette, pCGN3223, to create pCGN5528.
- the Hindlll fragment of pCGN5528 containing the napin 5' regulatory region, the Ma29 coding region, and the napin 3' regulatory region was inserted into the Hindlll site of pCGN 1557 to create ⁇ CGN5531.
- Two copies of the napin transcriptional unit were inserted in tandem. This tandem construct can permit higher expression of the desaturases per genetic loci.
- pCGN55 l was introduced inio Brassica napus cv.LP004 via Agrobacterium mediated transformation.
- the fatty acid composition of twenty-seed pools of mature T2 seeds was analyzed by GC.
- Table 2 shows the results obtained with independent transformed Sines as compared to non-transformed LP004 seed
- the transgenic seeds containing pCGN5531 contain two fatty acids that arc not present in the control seeds, tentatively identified as taxoleic acid (5,9-18:2) and pinolenic acid (5.9.12- 18:3). based on their elution relative to oleic and linoleic acid. These would be the expected products of ⁇ 5 desaiuration of oleic and linoleic acids. No other differences in fatty acid composition were observed in the transgenic seeds.
- Example 3 The construction of pCGN5531 (D5-desaturase) and fatty acid composition of T2 seed pools is described in Example 3. This example takes the seeds through one more generation and discusses ways to maximize the D5-desaturated fatty acids.
- Example 3 describes the fatty acid composition of T2 seed pools of ⁇ CGN55 1 -transformed B. napus cv. LP004 plants.
- T2 seed pools of ⁇ CGN55 1 -transformed B. napus cv. LP004 plants.
- half-seed analysis was done. Seeds were germinated overnight in the dark ai 30 degrees on water-soaked filter paper. The outer cotyledon was excised for GC analysis and the rest of the seedling was planted in soil. Results of some of these analyses are shown in the accompanying Table 3. D5.9-18-.2 accumulated to as high as i2% of the total fatty acids and
- D5.9,12-18:3 accumulated to up to 0.77% of the fatty acids.
- th pCGN5531 construct could be introduced into a high oleic acid variety of canoia.
- a high-oleic variety could be obtained by mutation, so-s ⁇ ppression, or antisense suppression of the D 12 and D I 5 desaturases or other necessary co-f ctors.
- the pCGN5S l construct could be introduced into a high linoleic strain of canoia. This could be achieved by crossing pCGN5531 -transformed plants with pCGN5542-(M. alpina Dl 2-desaturase) transformed plants. Alternatively, the DS and Dl 2 desaturases could be combined on one T-DNA for transformation.
- the transcriptional unit consisting of the napin 5'-regulatory region, the M. alpina Dl 2-desaturase coding region, and the napin :V-regulatory region can be cut out of pCGN5541 (described in CGAB320) as a Notl fragment.
- Notl/Xbal linkers could be ligated and the resulting fragment inserted int ⁇ the Xbal site of ⁇ CGN5531.
- the resulting plasmid would contain three napin tr_n_cnptional units containing the ⁇ . alpina Dl 2 desaturase, and two copies of the napin/ A/, alphm ' a D5 desaturase/napin unit, all oriented in the same direction as the 35S/nptII/rml transcriptional unit used for selection of transformed tissue.
- a nucleic acid sequence from a partial cDNA clone, Ma524, encoding a ⁇ 6 fatty acid desaturase from Mortierella alpina was obtained by random sequencing of clones from the M. alpina cDNA library.
- the a524 cDNA was modified by PCR to introduce cloning sites using the following primers:
- PCR produci was subcloned into pAMPl (GIBCOBRL) using the CloneAmp system (GIBCOBRL) to create pCGN5535 and the ⁇ 6 desaturnse sequence was verified by • equencing of both strands.
- the Ma524 coding region was cut out of pCGN5535 as an Xhol fragment and inserted into the Sail site of the napin expression cassette, pCGN3223. to create pCGN5536.
- the Notl fragment of pCGN5536 containing the napin 5' regulatory region, the Ma524 coding region, and the napin 3' regulatory region was inse ⁇ ed into the Notl site of pCGN 1557 to create pCGN5538.
- pCGN5538 was introduced into Brassica napus cv.LP004 via Agrobacterium mediated transformation, Maturing T2 .seeds were collected from 6 independent transformation events in the greenhouse. The fatty acid composition of single seeds was analyzed by GC.
- Table 4 shows the results of control LP004 seeds and six 5538 lines. All of the 5538 lines except #8 produced seeds containing GLA. Presence of GLA segregated in these seeds as is expected for the T2 selfed swid population. In addition to GLA, the M. alpina ⁇ 6 desat ⁇ rase is' apable of producing 18:4
- Example 5 described construction of pCGN5538 designed to express the M. alpina D6 desaturase in seeds of tran.sgenic canoia.
- Table 4 in thai example showed example, of single seed analyses from 6 independent transgenic events.
- Table 5 shows the fatty acid composition of 20-seed pools of T2 seed from each event. Seven of the lines contained more than 2% of the D6,9 18:2 in the seed pools. To identify and select plants with high amounts of D6,9 18:2 to be taken ⁇ n to subsequent generations, half-seed analysis was done. Seeds were germinated overnight in the dark at 30 degrees, on water-soaked filter paper. The outer cotyledon was excised for GC analysis and the rest of the seedling was planted in soil.
- T2 plants were grown in the greenhouse to produce T3 seed. The selection cycle was repeated; pools of T3 seed were analyzed for D6.9 18:2, T3 half-seeds were dissected and analyzed, and selected T3 plants were grown in the greenhouse to produce T4 seed. Pools of T4 se d were analyzed for fatty acid composition. Table 5 summarizes the results of this process for lines derived from one of the original transgenic events, 5538-
- the pCGN5538 construct could be introduced into a high oleic acid variety of canoia either by transformation or crossing.
- a high-oleic variety could be obtained by mutation, co-suppression, or mtiscnse suppression of the D12 and D15 desaturases or other necessary co- factors.
- Example 7 Identification of potentially useful Dl5/ ⁇ -3 desaturases from other organisms
- cDNA libraries were constructed from total RNA isolated from Schizochytrium (unknown species - proprietary strain supplied by Kelco in San Diego). Plasmid-based cDNA libraries were constructed in pSPORTl (GIBCO-BRL) following manufacturer's instructions using a commercially available kit (GIBCO-BRL). Random cDNA clones were sequenced and nucleic acid sequences that encode putati ve desaturases were identified through BLAST search of the databases and comparison to known
- TELECOMMUNICATION INFORMATION (A) TELEPHONE: ( 15) 433-4150 (B) TELEFAX: ( I S) 433-8716 (C) TELEX: N/A
- TCCATCGAOG GTTCGCCGAt CGTGCTGCTT CAGTACTTTC TCCCTTACCT TX-TTG ⁇ GAAC 960
- MOLECULE TYPE DNA (genomic)
Abstract
The present invention relates to compositions and methods for preparing polyunsaturated long chain fatty acids in plants, plant parts and plant cells, such as leaves, roots, fruits and seeds. Nucleic acid sequences and constructs encoding fatty acid desaturases, including Δ5-desaturases, Δ6-desaturases and Δ12-desaturases, are used to generate transgenic plants, plant parts and cells which contain and express one or more transgenes encoding one or more desaturases. Expression of the desaturases with different substrate specificities in the plant system permits the large scale production of polyunsaturated long chain fatty acids such as docosahexaenoic acid, eicosapentaenoic acid, α-linolenic acid, gamma-linolenic acid, arachidonic acid and the like for modification of the fatty acid profile of plants, plant parts and tissues. Manipulation of the fatty acid profiles allows for the production of commercial quantities of novel plant oils and products.
Description
POLYUNSATURATED FATTY ACIDS IN PLANTS
Field of the Invention
This invention relates to modulating levels of enzymes and/or eπfcyme components capable of altering the production of long chain polyunsaturated fatty acids (PUFAS) in a host plant. The invention is exemplified by the production of PUFAS in plants.
Three main families of polyunsaturated faity acids (PUFAs) are the 3 fatty acids, exemplified by arachidonic acid, the o>9 fatty acids exemplified by Mead acid, and the ω6 fatty a<>ids, exemplified by eicosapentaenoic acid. PUFAs are important components of the plasma membrane of the cell, where ihey may be found in such forms as phospholipids. PUFAs also serve as precursors to other molecules of importance in human beings and animals, including the prostacyclins, leukoirienes and prostaglaπdins. PUFAs are necessary for proper development, particularly in the developing infant brain, and for tissue formation and repair.
Four major long chain PUFAs of importance include docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), which are primarily found in different types of fish oil, ga mu-linolenic acid (GLA), which is found in the seeds of a number of plants, including evening primrose (Oenoiheru hiennis). borage (Borago offtcinalis) and black currants (Rώ' es nigrum), and siearidonic acid (SDA), which is found in marine oils and plant seeds. Both GLA and another important long chain PUFA, arachidonic acid (ARA), are found in filamentous fungi. A A can be purified from animal tissues including liver and adrenal gland. Mead acid accumulates in essential fatty acid deficient animals.
For DHA, a number of sources exist for commercial production including a variety of marine organisms, oils obtained from cold water marine fish, and egg yolk fractions. For ARA. microorganisms including the genera M rtierellu, Entoniophthoru, Phylium and F rphyridi m can be used for commercial production. Commercial sources of SDA include the genera Trichodexmu and
_τ.
Echium. Commercial sources of GLA include evening primrose, black currants and borage. Howev r, there ire several disadvantages associated with commercial production of PUFAs from natural sources. Natural sources of PUFAs. such as animals and plants, lend to have highly heterogeneous oil compositions. The oils obtained from these sources therefore can require extensive purification to separate out one or more desired PUFAs or to produce an oil which is enriched in one or more PUFA. Natural sources also are subject to uncontrollable fluctuations in availability. Fish stocks may undergo natural variation or may be depleted by overfishing. Fish oils have unpleasant tastes and odors, which may be impossible to economically separate from the desired product, and can render such products unacceptable as food supplements. Animal oils, and particularly fish oils, can accumulate environmental pollutants. Weather and disease can cause fluctuation in yields from both fish and plant sources. Cropland available for production of alternate oil-producing crops is subject lυ competition from the steady expansion of human populations and the associated increased need for food production on the remaining arable land. Crops which do produce PUFAs, such as borage, have not been adapted to commercial growth and may not perform well in monoculture. Growth of such crops is thus not economically competitive where more profitable and better established crops can be grown. Large scale fermentation of organisms such as Mortierella is also expensive. Natural animal tissues contain low amounts of ARA and are difficult to process. Microorganisms such as Porphy dium and Mortierella are difficult to cultivate on a commercial scale.
Dietary supplements and pharmaceutical formulations containing PUFAs can retain the disadvantages of the PUFA source. Supplements such as fish oil capsules can contain low levels of the particular desired component and thus require large dosages. High dosages result in ingestion of high levels of undesired components, including contaminants. Care must be taken in providing fatty acid supplements, as overaddition may result in suppression of endogenous bi synthetic pathways and l ad to competition with other necessary fatty acids in various lipid fractions in vivo, leading to undesirable results. For example, Eskimos having a diet high in <ή3 fatty acids have an increased tendency to bleed (U.S. Pat. No.
4,874,603). Unpleasant tastes and odors of the supplements can make such regimens undesirable, and may inhibit compliance by the patient.
A number of enzymes are involved in PUFA biosynthesis. Linoleic acid
(LA, 18:2 Δ9. 12) is produced from oleic acid (18; I Δ9) by a Δ 12-desaturase. GLA ( 18:3 Δ6. 9. 12) is produced from linoleic acid (LA, 18:2 Δ9, 12) by a Δ6- desaturase. ARA (20:4 Δ5. 8. 1 1. 14) production from DGLA (20:3 Δ8, 1 1 , 14) is catalyzed by a Δ5 -desaturase. However, animals cannot desaturate beyond the Δ9 position and therefore cannot convert oleic acid ( 18:1 Λ9) into linoleic acid (1 :2
Δ9, 12), Likewise, α-Iinolenic acid (ALA, 18:3 Δ9, 12, 15) cannot be synthesized by mammals. Other eukaryotes, including fungi and plants, have enzymes which desaturate at positions Δ21 and Δl 5. The major poly-unsaturatcd fatty acids of animals therefore arc either derived from diet and or from desaturation and i elongation of linoleic acid ( 18:2 Δ9, 12) or oc-linolenic acid (18:3 Δ9, 12, 15).
Poly-unsaturatcd fatty acids are considered to be useful for nutritional, pharmaceutical, industrial, and other purposes. An expansive supply of polyunsaturated fatty acids from natural sources and from chemical synthesis are not sufficient for commercial needs. Therefore Lt is of interest to obtain genetic material involved in PUFA biosynthesis from species that naturally produce these fatty acids and to express the isolated material alone or in combination in a hctcrυlogυus system which can be manipulated to allow production of commercial quantities of PUFAS.
SUMMARY OF THE INVENTION
Novel compositions and methods are provided for preparation of polyunsaturated long chain fatty acids and desaturases in plants and plant cells. The methods involve growing a host plant cell of interest transformed with an expression cassette functional in a hose plant cell, the expression casse'te comprising a cranscriptional and translational initiation regulatory region, joined in reading frame 5' to a DNA sequence encoding a desaturase polypeptide capable of modulating the production of PUFAs. Expression of the desaturase polypeptide provides for an alteration in the PUFA profile of host plant cells as a result of
altered concentrations of enzymes involved in PUFA biosynthesis. Of particular interest is the selective control of PUFA production in plant tissues and/or plant parts such as leaves, roots, fruits and seeds. The invention finds use for example in the large scale production of DHA, Mead Acid EPA, ARA, Stearidonic acid and GLA and for modification of the fatty acid profile of edible plant tissues and/or plant parts.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure I shows possible pathways for the synthesis of Mead acid (20:3 Δ5, 8, 1 1), arachidonic acid (20:4 Δ5, 8, 1 1, 14) and stearidonic acid ( 18:4 Δ6, 9. 12. 15) from palmitic acid (C^) from a variety of organisms, including algae,
Mortierella and humans. These PUFAs can serve as precursors to other molecules important for humans and other animals, including prostacyclins, lcukotrienes, and prostaglaπdins, some of which are shown.
Figure 2 shows possible pathways for production of PUFAs in addition to ARA, including taxoleic acid and pinolenic, again compiled from a variety of organisms.
BRIEF DESCRIPTION OF THE SEQUENCE LISTINGS
SEQ ID NO: I shows DNA sequence from a Schizochytrium clone with homology to both 12 and Δ 15 desaturases. SEQ ID NO 2 shows peptide sequence from a Schizochytrium clone with homology to both Δ 12 and Δ15 desaturases.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
In order to ensure a complete understanding of the invention, the following definitions are provided: Δ5-Desaturase: Δ5 desaturase is an enzyme which introduces a double bond between carbons 5 and 6 from the carboxyl end of a fatty acid molecule.
Δ6-Desaturase: Δ6-desaturase is an enzyme which introduces a double bond between carbons 6 and 7 from the carboxyl end of a fatty acid molecule.
Δ9-De_aturase: Δ9-desaturase is an enzyme which introduces a double bond between carbons 9 and 10 from the carboxyl end of a tatty acid molecule.
ΔI2-Dcsatura&e: Δ 12-desaturase is an enzyme which introduces a double bond between carbons 12 and 13 from the carboxyl end of a fatty acid molecule.
Fatty Acids: Fatty acids are a class of compounds containing a long hydrocarbon chain and a terminal carboxylate group. Fatty acids include the following:
Taking into account these definitions, the present invention is directed (o novel DNA sequences, DNA constructs, methods and compositions are provided which permit modification of the poly-unsaturated long chain fatty acid content of plane cells. Plant cells are transformed with an expression cassette comprising a
DNA encoding a polypeptide capable of increasing the amount of one or more PUFA in a plant cell. Desirably, integration constructs may be prepared which provide for integration of the expression cassette into the genome of a host cell. Host cells are manipulated to express a sense or antisense DNA encoding a polypcptidc(s) that has desaturase activity. By "desaturase" is intended a polypeptide which can desaturate one or more fatty acids to produce a mono- or poly-unsaturated fatty acid or precursor thereof of interest. By "polypeptide" is meant any chain of amino acids, regardless of length or post-translational modification, for example, glycosylatioπ or phosphorylation. The substratc(s) for the expressed enzyme may be produced by the host cell or may be exogenously supplied. t
To achieve expression in a host cell, the transformed DNA is operably associated with transcriptional and translational initiation and termination regulatory regions thai are functional in the host cell. Constructs comprising the gene to be expressed can provide for integration into the genome of the host cell or can autonomously replicate in the host cell. For production of linoleic acid (LA), the expression cassettes generally used include a cassette which provides for Δ12 desaturase activity, particularly in a host cell which produces or can take up oleic acid. For production of ALA, the expression cassettes generally used, include a cassette which provides for Δl 5 or ω3 desaturase activity, particularly in a host cell which produces or euπ take up LA. For production of GLA or SDA, the expression cassettes generally used include a cassette which provides for Λ6 desaturase activity, particularly in a host cell which produces or can take up LA or ALA,
respectively. Production of ω6-iype unsaturated fatty acids, such as LA or GLA, is favored in a plant capable of producing ALA by inhibiting the activity of a Δ15 or ω3 type desaturase; this is accomplished by providing an expression cassette for an ami sense Δ15 or »3 transcript, or by disrupting a ΔI5 or α>3 desaturase gene. Similarly, production of LA or ALA is favored in a plant having Δ6 desaturase activity by providing an expression cassette for an an ti sense Δ6 transcript, or by disrupting a Δ6 desaturase gene Production of oleic acid likewise is favored in a plant having Δl 2 desaturase activity by providing an expression cassette for an antisense Δ12 transcript, or by disrupting a Λl 2 desaturase gene. For production of ARA, the expression cassette generally used provides for Δ5 desaturase activity, particularly in a ho.st cull which produces or can take up DCiLA. Production of ω6- type unsaturated fatty icids. such as ARA, is favored in a plant capable of producing ALA by inhibiting the activity of a Δ15 or ω3 type desaturase; this is accomplished by providing an expression cassette for an antisense Δ15 or ω3 transcript, or by disrupting a Δ 15 or ω3 desaturase gene.
TRANSGENIC PLANT PRODUCTION OF FATTY ACIDS
Transgenic plant production of PUFAs offers several advantages over purification from natural sources such as fish or plants. Production of fatty acids from recombinant plants provides the ability to alter the naturally occurring plant fatty acid profile by providing new synthetic pathways in the host or by suppressing undesired pathways, thereby increasing levels of desired PUFAs, or conjugated forms thereof, and decreasing levels of undesired PUFAs. Production of fatty acids in transgenic plants also offers the advantage that expression of desaturase genes in particular tissues and/or plant parts means that greatly increased levels of desired PUFAs in those tissues αnd/or parts can be achieved, making recovery from those tissues more economical For example the desired PUFAs can be expressed in seed; methods of isolating seed oils are well established. n addition to providing a source foi purification ot desired PUFAs. seed oil components can be manipulated through expression of desaturase genes, either alone or in combination with other genes such as elongate., to provide seed oils having a particular PUFA profile in concentrated tυrm The concentrated seed oils then can be added 10 animal milks
and/or synthetic or semi-synthetic milks to serve as infant formulas where human nursing is impossible or undesired, or in cases of malnourishmenl or disease in both adults and infants.
For production of PUFAs. depending upon the host cell, the availability of substrate, and the desired end product(s). several polypeptidcs, particularly desaturases, are of interest including those polypeptides which catalyze the conversion of stearic acid to oleic acid. LA to GLA, of ALA to SDA, of oleic acid to LA, or of LA to ALA, which includes enzymes which desaturate at the Δ6, Δ9, Δ12, Δ15 or ω3 positions. Considerations for choosing a specific polypeptide having desaturase activity include the pH optimum of the polypeptide, whether the polypeptide is a rate limiting enzyme or a component thereof, whether the desaturase used is essential for synthesis of a desired poly-unsaturated fatty acid, and/or co-factors required by the polypeptide. The expressed polypeptide preferably has parameters compatible with the biochemical environment of its location in the host cell. For example, the polypeptide may have to compete for substrate with other en/.ymes in the host cell. Analyses of the K-, and specific activity of the polypeptide in question therefore are considered in determining the suitability of a given polypeptide for modifying PUFA production in a given host cell. The polypeptide used in a particular situation therefore is one which can function under the conditions present in the intended host cell but otherwise can be any polypeptide having desaturase activity which has the desired characteristic of being capable of modifying the relative production of a desired PUFA. A scheme for the synthesis of arachidonic acid (20:4 Δ5. 8, 11, 14) from palmitic acid (Cι6) is shown in Figure 1. A key enzyme in this pathway is a Δ5-desaturase which converts DH-γ-linolenic acid (DGLA, eicosatrienoic acid) to ARA. Conversion of -linolentc acid (ALA) to stearidonic acid by a Δ6-desaturase is also shown. Production of PUFAs in addition to ARA, including EPA and DHA is shown in Figure 1. A key enzyme in the synthesis of arachidonic acid (20:4 Δ5, 8, 11, 14) from stearic acid (Cl ) is a Δ6-des_turas- which converts the linoleic acid into γ- linolenic acid. Conversion of α-liπolcnic acid (ALA) to stearidonic acid by a Δ6- desaturase also is shown. For production of ARA, the DNA sequence used encodes
a polypeptide having Λ5 desaturase activity. In particular instances, this can be coupled with an expression cassette which provides for production of a polypeptide having Δ6 desaturase activity and, optionally, a transcription cassette providing for production of antisense sequences to a Δ 15 transcription product. The choice of combination of cassettes used depends in part on the PUFA profile of the host cell.
Where the host cell Δ5-desaturase activity is limiting, overexpression of Δ5 desaturase alone generally will be sufficient to provide for enhanced ARA production.
SOURCES OF POLYPEPTIDES HAVING DESATURASE ACTIVITY
As sources of polypeptides having desaturase activity and oligoπucleotides encoding such polypeptides are organisms which produce a desired polyunsaturated fatty acid. As an example, microorganisms having an ability to produce ARA can be used as a source of A5-desatura.se genes; microorganisms which GLA or SDA can be used as a source of Δ6-desaturase and or Δl 2- desarurase genes. Such microorganisms include, for example, those belonging to the genera Mortierella. Conidiobolus, Pythium, Phytophathora, Penicillium, Porphyridium, Coidosporium, Mucor, Fusurium, A.ψergillus, Rhodotorula, and Entomophthora. Within the genus Porphyridium, of particular interest is Porphyridium cruentum. Wiihin the genus Mortierella, of particular interest are
Mortierella elongata. Mortierella exigua, Mortierella hygrophila, Mortierella rumanniuna, var. angulispora, and Mortierella alptna. Within the genus Mucor, of particular interest are Mucor circinellυulex and Mucor javanicus.
DKAs encoding desired desaturases can be identified in a variety of ways. As an example, a source of the desired desaturase, for example gcπomic or cDNA libraries from Mortierella. is screened with detectable enzymatically- or chemically-synthesized probes, which can be made from DNA, RNA.' or hon- naturally occurring nucleotides, or mixtures thereof. Probes may be enzymatically synthesized from DNAs of known desamrases for normal or reduced-stringency hybridization methods. Oligonucleotide probes also can be used to screen sources and can be based on sequences υf known desaturases, including sequences
conserved among known desaturases, or on peptide sequences obtained from the desired purified protein. Oligonucleotide probes based on amino acid sequences can be degenerate to encompass the degeneracy of the genetic code, or can be biased in favor of the preferred codons of the source organism. Oligomicleotides also can be used as primers for PCR from reverse transcribed mRNA from a known or suspected source; the PCR product can be the full length cDNA or can be used to generate a probe to obtain the desired full length cDNA. Alternatively, a desired protein can be entirely sequenced and total synthesis of a DNA encoding that polypeptide performed. Once the desired genomic or cDNA has been isolated, it can be sequenced by known methods. It is recognized in the art that such methods are subject to errors, such that multiple sequencing of the same region is routine and is still expected to lead to measurable rates of mistakes in the resulting deduced sequence, particularly in regions having repeated domains, extensive secondary structure, or unusual base compositions, such as regions with high GC base content. When discrepancies arise, resequencing can be done and can employ special methods. Special methods can include altering sequencing conditions by using: different temperatures; different enzymes; proteins which alter the ability of oligonucleotides to form higher order structures; altered nucleotid s such as ITP or methylated dGTP; different gel compositions, for example adding formamide; different primers or primers located at different distances from the problem region; r different templates such as single stranded DNAs. Sequencing of mRNA can also be employed.
For the most part, some or all of the coding sequence for the polypeptide having desaturase activity is from a natural source. In some situations, however, it is desirable to modify all or a portion of the codons, for example, to enhance expression, by employing host preferred codons. Host preferred codons can be determined from the codons of highest frequency in the proteins expressed in the largest amount in a particular host species of interest. Thus, the coding sequence for a polypeptide having desaturase activity can be synthesized in whole or in pan.
All or portions of the DNA also can be synthesized to remove any destabilizing sequences or regions of secondary tructure which would be present in the
transcribed mRNA. All or portions of the DNA also can be synthesized to alter the base composition to one more preferable in the desired host cell. Methods for synthesizing sequences and bringing sequences together are well established in the literature. In
mutagenesis and selection, site-directed mutagenesis, or other means can be employed to obtain mutations of naturally occurring desaturase genes to produce a polypeptide having desaturase activity in vivo with more desirable physical and kinetic parameters for function in the host cell, such as a longer half- life or a higher rate of production of a desired polyunsaturated fatty acid.
Desirable cDNAs have less than 60% A+T composition, preferably less than 50% A+T composition. On a localized scale of a sliding window of 20 base pairs, it is preferable that there are no localized regions of the cDNA with greater than 75% A+T composition; with a window of 60 base pairs, it is preferable that there are no localized regions of the cDNA with greater than 60%, more preferably no localized regions with greater than 55% A+T composition.
Mortierella alpina Desaturases
Of particular interest are the Mortierella alpina Δ5-desaturase, Δ6- desaturase, Δl 2-desaturase and Δ15 desaturase. The gene encoding the Mortierella alpina Δ5-dcsaturase can be expressed in transgenic plants to effect greater synthesis of ARA from DGLA Other DNAs which art substantially identical in sequence to the Mortierella alpina Δ5-desaturase DNA, or which encode polypeptides which are substantially identical in sequence to the Mortierella alpina Δ5-desaturase polypeptide, also can be used. The gene encoding the Mortierella alpina Δ6-desaturase can be expressed in transgenic plants or animals to effect greater synthesis of GLA from linoleic acid or of stearidonic acid (SDA) from ALA. Other DNAs which are substantially identical in sequence to the Monierelia alpina Δ6-desaturase DNA, or which encode polypeptides which are substantially identical in sequence to the Mortierella alpina Δ6-desaιurase polypeptide, also can be used.
The gene encoding the Mortierella alpina Δ12-desaturase can be expressed in transgenic plants to effect greater synthesis of LA from oleic acid. Other DNAs
which are substantially identical to the Mortierella alpina Δ 12-desaturase DNA, or which encode polypeptides which are substantially identical to the Mortierella alpina Δl 2-desaturase polypeptide, also can be used.
By substantially identical in sequence is intended an amino acid sequence or nucleic acid sequence exhibiting in order of increasing preference at least 60%.
80%. 90% or 95% homology to the Mortierellu alpina Δ5-desaturase amino acid sequence or nucleic acid sequence encoding the amino acid sequence. For polypeptides, the length of comparison sequences generally is at least 16 amino acids, preferably at least 20 amino acids, or most preferably 35 amino acids. For nucleic acids, the length of comparison sequences generally is at least 50 nucleotides, preferably at least 60 nucleotides, and more preferably at least 75 nucleotides. and most preferably, 1 10 nucleotides. Homology typically is measured using sequence analysis software, for example, the Sequence Analysis software package of the Genetics Computer Group, University of Wisconsin Biotechnology Center, 1710 University Avenue, Madison, Wisconsin 53705, MEGAligπ
(DNAStar, Inc., 1228 S. Park St., Madison, Wisconsin 53715). and Mac Vector (Oxford Molecular Group, 2105 S. Bascom Avenue. Suite 200. Campbell. California 95008). Such software matches similar sequences by assigning degrees of homology to various substitutions, deletions, and other modifications. Conservative substitutions typically include substitutions within the following groups: glycine and alanine; valine, isolcucine and leucine; aspaπic acid, glutamic acid, asparagine, and glutamine; serine and threonine; lysine and arginine; and phenylalanine and tyrosine. Substitutions may also be made on the basis of conserved hydrophobicity or hydrophilicity (Kyte and Doolittle, J. Mol. Biol. 157: 105-132, 1982). or on the basis of the ability to assume similar polypeptide secondary structure (Chou and Fasman, Adv. £wzymo/. 47: 45-148, 1978).
EXPRESSION OF DESATURASE GENES
Once the DNA encoding a desaturase polypeptide has been obtained, it is placed in a vector capable of replication in a host cell, or is propagated in vitro by means of techniques such as PCR or long PCR. Replicating vectors can include plasmids, phage, viruses, cosmids and the like. Desirable vectors include those
useful for mutagenesis of the gene of interest or for expression of the gene of interest in host cells. The technique of long PCR has made in vitro propagation of targe constructs possible, so that modifications to the gene of interest, such as mutagenesis or addition of expression signals, and propagation of the resulting constructs can occur entirely in vitro without the use of a replicating vector or a host cell.
For expression of a desaturase polypeptide, functional transcriptional and translational initiation and termination regions are operably linked to the DNA encoding the desaturase polypeptide. Transcriptional and translational initiation and termination regions are derived from a variety of nonexclusive sources, including the DNA to be expressed, genes known or suspected to be capable of expression in the desired system, expression vectors, chemical synthesis, or from an endogenous locus in a host cell. Expression in a plant tissue and/or plant pare presents certain efficiencies, particularly where the tissue or part is one which is easily harvested, such as seed, leaves, fruits, flowers, roots, etc. Expression can be targeted to that location within the plant by using specific regulatory sequences, such as those of USPN 5,463.174, USPN 4,943,674. USPN 5, 106.739, USPN 5, 175,095, USPN 5,420,034, USP 5.188.958, and USPN 5,589,379. Alternatively, the expressed protein can be an enzyme which produces a product which may be incorporated, either directly or upon further modifications, into a fluid fraction from the host plant. In the present case, expression of desaturase genes, or antisense desaturase transcripts, can alter the levels of specific PUFAs, or derivatives thereof, found in plant parts and or plant tissues. The Δ5-desaturasc polypeptide coding region is expressed either by itself or with other genes, in order to produce tissues and/or plant pans containing higher proportions of desired
PUFAs or in which the PUFA composition more closely resembles that of human breast milk (Pricto et aL. PCT publication WO 95/24494). The termination region can be derived from the 3' region of the gene from which the initiation region was obtained or from a different gene. A large number of term i nut ion regions are known to and have been found to be satisfactory in a variety of hosts from the same and different genera and species. The termination region usually is selected more as a matter of convenience rather than because of any particular property.
The choice of a host cell is influenced in pan by the desired PUFA profile of the transgenic cell, and the native profile of the host cell. As an example, for production of linoleic acid from oleic acid, the DNA sequence used encodes a polypeptide having ΔI2 desaturase activity, and for production of GLA from linoleic acid, the DNA sequence used encodes a polypeptide having Δ6 desaturase activity. Use of a host cell which expresses Δ 12 desaturase activity and lacks or is depleted in Δ15 desaturase activity, can be used with an expression cassette which provides for overexpression of Δ6 desaturase alone generally is sufficient to provide for enhanced GLA production in the transgenic cell. Where the host cell expresses Δ9 desaturase activity, expression of both a Δl 2- and a Δ6-desarurase can provide for enhanced GLA production. In particular instances where expression of Δ6 desaturase activity is coupled with expression of Δ 12 desaturase activity, it is desirable that the host cell naturally have, or be mutated to have, low Δ15 desaturase activity. Alternatively, a host cell for Δ6 desaturase expression may have, or be mutated to have, high Δl 2 desaturase activity.
Expression in a host cell can be accomplished in a transient or stable fashion. Transient expression can occur from introduced constructs which contain expression signals functional in the host cell, but which constructs do not replicate and rarely integrate in the host cell, or where the host cell is not proliferating. Transient expression also can be accomplished by inducing the activity of a regulatable promoter operably linked to the gene of interest, although such inducible systems frequently exhibit a low basal level of expression. Stable expression can be achieved by introduction of a construct that can integrate into the host genome or that autonomously replicates in the host cell. Stable expression of the gene of interest can be selected for through the use of a selectable marker located on or transfected with the expression construct, followed by selection for cells expressing the marker. When stable expression results from integration, integration of constructs can occur randomly within the host genome or can be targeted through the use of constructs containing regions of homology with the host genome sufficient to target recombination with the host locus. Where constructs
are targeted to an endogenous locus, all or some of the transcript i onal and translational regulatory regions can be provided by the endogenous locus.
When increased expression of the desaturase polypeptide in the source plant is desired, several methods can be employed. Additional genes encoding the desaturase polypeptide can be introduced into the host organism. Expression from the native desaturase locus also can be increased through homologous recombination, for example by inserting a stronger promoter into the host genome to cause increased expression, by removing destabilizing sequences from either the mRNA or the encoded protein by deleting that information from the host genome, or by adding stabilizing sequences to the mRNA (see USPN 4,910, 1 1 and USPN
5,500,365.)
When it is desirable to express more than one different gene, appropriate regulatory regions and expression methods, introduced genes can be propagated in the host cell through use of replicating vectors or by integration into the host genome. Where two or more genes are expressed from separate replicating vectors, it is desirable that each vector has a different means of replication. Each introduced construct, whether integrated or not. should have a different means of selection and should lack homology to the other constructs to maintain stable expression and prevent reassortmeπi of elements among constructs. Judicious choices of regulatory regions, selection means and method of propagation of the introduced construct can be experimentally determined so that all introduced genes are expressed at the necessary levels to provide for synthesis of the desired products.
Constructs comprising the gene of interest may be introduced into a host cell by standard techniques. These techniques include transfection, infection, holistic impact, electroporaiion, microinjection. scraping, or any other method which introduces the gene of interest into the host cell (see USPN 4,743,548, USPN 4,795.855, USPN 5,068.193, USPN 5, 188,958, USPN 5.463,174, USPN 5,565,346 and USPN 5,565,347). For convenience, a host cell which has been manipulated by any method to take up a DNA sequence or construct will be referred to as "transformed" or "rccombinant" herein. The subject host will have at least have one copy of the expression construct and may have two or more, depending upon
whether the gene is integrated into the genome, amplified, or is present on an extrachromosomal element having multiple copy numbers.
The transformed host cell can be identified by selection for a marker contained on the introduced construct. Alternatively, a separate marker construct may be introduced with the desired construct, as many transformation techniques introduce many DNA molecules into host cells. Typically, transformed hosts are selected for their ability to grow on selective media. Selective media may incorporate an antibiotic or lack a factor necessary for growth of the untransformed host, such as a nutrient or growth factor. An introduced marker gene therefor may confer antibiotic resistance, or encode an essential growth factor or enzyme, and permit growth on selective media when expressed in the transformed host cell. Desirably, resistance to kanamycin and the amino glycoside G 18 are of interest (see USPN 5,034,322). Selection of a transformed host can also occur when the expressed marker protein can be detected, either directly or indirectly. The marker protein may be expressed alone or as a fusion to another protein. The marker protein can be detected by its enzymatic activity; for example β gaiaclosidase can convert the substraie X-gal to a colored product, and lucifεrase can convert luciferin to a light-emitting product. The marker protein can be detected by its light-producing or modifying characteristics; for example, the green fluorescent protein cΛ equorea ictoria fluoresces when illuminated with blue light.
Antibodies can be used to detect the marker protein or a molecular tag on, for example, a protein of interest. Cells expressing the marker protein or tag can be selected, for example, visually, or by techniques such as FACS or panning using antibodies. The PUFAs produced using the subject methods and compositions may be found in the host plant tissue and/or plant part as free fatty acids or in conjugated forms such as acylglycerols, phυspholipids, sulfolipids or glycolipids. and may be extracted from the host cell through a variety of means well-known in the art. Such means may include extraction wiih organic solvents, sonication, supercritical fluid extraction using for example carbon dioxide, and physical means such as presses, or combinations thereo Of particular interest is extraction with hexane or methanol and chloroform. Where desirable, the aqueous layer can be acidified to
protonate negatively charged moieties and thereby increase partitioning of desired products into the organic layer. After extraction, the organic solvents can be removed by evaporation under a stream of nitrogen. When isolated in conjugated forms, the products are enzymatically or chemically cleaved to release the free fatty acid or a less complex conjugate of interest, and are then subjected to further manipulations to produce a desired end product. Desirably, conjugated forms of fatty acids are cleaved with potassium hydroxide.
PURIFICATION OF FATTY ACIDS
If further purification is necessary, standard methods can be employed. Such methods include extraction, treatment with urea, fractional crystallization,
HPLC, fractional distillation, silica gel chromatography, high speed centrifugatioπ or distillation, or combinations of these techniques. Protection of reactive groups, i such as the acid or alkenyl groups, may be done at any step through known techniques, for example alkylation or iodination. Methods used include methylation of the fatty acids to produce methyl esters. Similarly, protecting groups may be removed al any step. Desirably, purification of fractions containing ARA, DHA and EPA is accomplished by treatment with urea and/or fractional distillation.
USES OF FATTY ACIDS The uses of the fatty acids of subject invention are several. Probes based on the DNAs of the present invention may find use in methods for isolating related molecules or in methods to detect organisms expressing desaturases. When used as probes, the DNAs or oligonuclcotides need to be detectable. This is usually accomplished by attaching a label either at an internal site, for example via incorporation of a modified residue, or at the 5' or 3' terminus. Such labels can be directly detectable, can bind to a secondary molecule that is detectably labeled, or can bind to an unlabelled secondary molecule and a detectably labeled tertiary molecule: this process can be extended as long as is practical to achieve a satisfactorily detectable signal without unacceptable levels of background signal. Secondary, tertiary, or bridging systems can include use of antibodies directed against any other molecule, including labels or other antibodies, or can involve any
molecules which bind to each other, for example a biotin-streptavidin avidin system. Detectable labels typically include radioactive isotopes, molecules which chemically or enzymatically produce or alter light, enzymes which produce detectable reaction products, magnetic molecules, fluorescent molecules or molecules whose fluorescence or light-emitting characteristics change upon binding. Examples of labelling methods can be found in USPN 5,01 1 ,770. Alternatively, the binding of target molecules can be directly detected by measuring the change in heat of solution on binding of probe to target via isothermal lit ration caiorimetry, or by coating rhe probe or target on a surface and detecting the change in scattering of light from the surface produced by binding of target or probe, respectively, as may be done with the BLAcore system.
The invention will be better understood by reference to the following non- limiting examples.
Examples Example 1
Expression of ω-3 desaturase from . e mans in transgenic plants.
The D15/ω-3 activity of Brassica napus can be increased by the expression of an ω-3 desaturase from C. elegans. The fat-1 cDNA clone (Gcnbank accession l li807; Spychalla, J. P., Kinney, A. J., and Browse, J. 1997 P.N.A.S. 94, 1 142-
1 147 was obtained from John Browse at Washington State University. The fat-1 cDNA was modified by PCR to introduce cloning sites using the following primers:
Fat-lforward:
5'-CUACUACUACUACTGCAGACAATGGTCGCTCATTCCTCAGA-3' Fat-1 reverse:
5'- CAUCAUCAUCAUGCGGCCGCTTACTTGGCCΓTTGCCTT - 3'
These primers allowed the amplification of the entire coding region and added Pstl and Notl .sites to the 5'- and 3'-ends, respectively. The PCR product was subcloned into pAMPl (GIBCOBRL) using the CloneAmp system (GIBCOBRL)
to create pCGN5562. The sequence was verified by sequencing of both strands to be sure no changes were introduced by PCR. For seed specific expression, the Fat- I coding region was cut out of pCGN5562 as a Pstϊ/Notl fragment and inserted between the Pstl/Notl sites of the binary vector. pCGN8623, to create pCGN5563. PCGN5563 can be introduced into Brassica napus via Agmhucterium-medi&xcd transformation.
Construction of pCGN8623
The polylinker region of the napin promoter cassette. pCGN7770, was replaced by ligating the following oligoπucleotides: 5 - TCGACCTGCAGGAAGCTTGCGGCCGCGGATCC -3' and
5'- TCGAGGATCCGCGGCCGCAAGCTTCCTGCAGG-3'. These oligonucleotides were .'igated into Sall/XhoI-digested pCGN7770 to produce pCGN861 . These oligos encode BamHI, Notl, Hindlll, and Pstl restriction sites. pCGN8619 contains the oligos oriented such that the Pstl site is closest to the napin 5' regulatory region. A fragment containing the napin 5' regulatory region, polylinker, and napin 3' region was removed from pCGN8619 by digestion with Asp7181. The fragment was blunt-ended by filling in the 5' overhangs with Klenow fragment then ligaied into pCGN5 l 39 that had been digested with Asp7l8I and Hindlll and blunt-ended by filling in the 5' overhangs with Klenow fragment. A plasmid containing the insert oriented so that the napin promoter was closest to the blunted A.sp7l 81 site of pCGN5139 and the napin 3' was closest to the blunted Hindlll site was subjected to sequence analysis to confirm both the insert orientation and the integrity of cloning junctions. The resulting plasmid was designated pCGN8623. To produce high levels of stearidonic acid in Brassica, the C. elegans ω-3 desaturase can be combined with D6- and D 12-desaturases from Mortierella alpina. PCGN5563-transformed plants may be crossed with pCGN5 44- transformed plants expressing the D6-and D 12-desarurascs.
The resulting FI seeds can be analyzed for stearidonic acid content and selected FI plants can be used for self-pollination to produce F2 seed, or as donors for production of dihaploids, or additional crosses.
An alternative method to combine the fat-1 cDNA with M. alpina D6 and Dl2 desaturases is to combine them on one T-DNA for transformation. The fat-1 coding region from pCϋN5562 can be cut out as a Pstl Notl fragment and inserted into Pstl Notl digested pCGN8619. The transcriptional unit consisting of the napin 5" regulatory region, the fat- 1 coding region, and the napin 3'-regulatory region can be cut out as a Sse83871 fragment and inserted into pCGN5544 cut with Sse8387I. The resulting plasmid would contain three napin transcriptional units containing the C. elegans ω-3 desaturase, M. alpina D6 desaturase, and M. alpina D) desaturase, all oriented in the same direction as the 35S/nptllΛml transcriptional unit used for selection of transformed tissue.
Example 2
Over-Expression of DlS-desaturase Activity in Transgenic Canola
The D15-desaturase activity of Brassica napus can be increased by over- expression of the D15-desaturase cDNA clone. A B. napus D 15-desαturase cDNA clone was obtained by PCR amplification of first-strand cDNA derived from B. napus cv. 212 R6. The primers were based on published sequence: Genbank # L I41 Arondel et al, 1992 Science 258: 1353-1355.
The following primers were used: Bndl5-FORWARD
S'-CUACUACUACUAGAGCTCAGCGATGGπGTTGCTATGGAC-T
BndlS-REVERSE
S^-CAUCAUCAUCAUGAATTCTTAATTGATTTTAGATTTG-^
These primers allowed the amplification of the entire coding region and added Sacl and EcoRI sites to the 5'- and 3'-ends, respectively
The PCR product was subcloned into pAMPl (GIBCOBRL) using the CloneAmp system (GIBCOBRL) to create pCGN5520. The sequence was verified by sequencing of both strands to be sure that the open reading frame remained intact.
For seed specific expression, the D15-desacurase coding region was cut out of pCGN5520 as a BamHI/Sall fragment and inserted between the Bglll and Xhol sites of the pCGN7770, to create pCGN5557. The Pstl fragment of pCGN5557 containing the napin 5'-regulatory region, B. napus D15-desaturase, and napin 3'- regulatory region was inserted into the Pstl site of the binary vector, pCGN5138 to produce pCGN5558. pCGN5558 was introduced into Brassica napus via Agrohacterium- tdx&ied transformation.
To produce high levels of stearidonic acid in Brassica, the D15-desaturase can be combined with D6- and D12-desaturases from Mortierella alpina. PCGN5558-transformed plants may be crossed with pCGN5544-transformed plants expressing the D6 and 12-desaturases. The resulting FI seeds can be analyzed for stearidonic acid content and selected FI planes can be used for self-pollination to produce F2 seed, or d donors for production of dihapioids. or additional crosses.
An alternative method to combine the B. napus Dl5-desaturase with M. alpina D6 and D 12 desaturases is to combine them on one T-DN A for transformation. The transcription cassette consisting of the napin 5'-regulatory region, the D 15-desaturasc coding region, and the napin 3'-regulatory region can be cut out of pCGN5557 as a Swal fragment and inserted into Swal-digested ρCGN5544. The resulting plasmid would contain three napin transcriptional units containing the M. alpina D6 desatura.se, the B. napus Dl5-dcsaturase, and the M. alpina D1 desaturase, all oriented in the same direction as the 35S/nρt!I/tmi transcriptional unit used for selection of transformed tissue.
Example 3
Expression of Δ5 De_atur>_se in Plants Expression in Leaves
Ma29 is a putative M. alpina D5 desaturase as determined by sequence homology. This experiment was designed to determine whether leaves expressing Ma29 (as determined by Northern) were able to convert exogenously applied DGLA (20:3) to ARA (20:4).
The Ma29 desaturase cDNA was modified by PCR to introduce convenient restriction sites for cloning. The desaturase coding region has been inserted into a d35 cassette under the control of the double 35S promoter for expression in Brassica leaves (pCGN5525) following standard protocols (see USPN 5,424,200 and USPN 5.106,739). Transgenic Brassica plants containing pCGN5525 were generaied following standard protocols (see USPN 5,188,958 and USPN 5,463.174).
In the first experiment, three plants were used: a control, LP004-1, and two transgenics,. 5525-23 and 5525-29. LP004 is & low-linolenic Brassica variety. Leaves of each were selected for one of three treatments: water, GLA or DGLA.
GLA and DGLA were purchased as sodium salts from NuChek Prep and dissolved in water at 1 mg/ml. Aliquots were capped under N_ and stored at -70 degrees C. Leaves were treated by applying a 50 μi drop to the upper surface and gently spreading with a gloved finger to cover the entire surface. Applications were made approximately 30 minutes before the end of the light cycle to minimize any photo- oxidation of the applied fairy acids. After 6 days of treatment one leaf from each treatment was harvested and cut in half through the mid rib. One half was washed with water to attempt to remove unincorporated fatty acid. Leaf samples were lyophilized overnight, and fatty acid composition determined by gas chromatography (GC). The results are shown in Table 1.
FaMy Add Analysis of Leaves from Ma29 Transgenic Brassica Plants
Table 1 - Continued Pally Add Analv-u of Leaτe» from Ma29 Transrtnic Brassica PUntt
π
Leaves treated with GLA contained from 1.56 to 2.4 wt% GLA. The fatty acid analysis showed that the lipid composition of control and transgenic leaves was essentially the same. Leaves of control plants treated with DGLA contained 1.2- 1.9 w% DGLA and background amounts of ARA (.26-.27 wt%). Transgenic leaves contained only .2- 7 wt% DGLA. but levels of ARA were increased (.74- 1.1 wt%) indicating that the DGLA was convened to ARA in these leaves.
Expression in Seed
The purpose of this experiment was to determine whether a construct with the seed specific napin promoter would enable expression in seed.
The a29 cDNA was modified by PCR to introduce Xhol cloning sites upstream and downstream of the start and stop codons, respectively, using the following primers: .
Madxho-forward : 5 -CUACUACUACUACTCGAGCAAGATGGGAACGGACCAAGG
Madxho-reverse:
S'-CAUCAUCAUCAUCTCGAGCTACTCTTCCTTGGGACGGAG
The PCR product was subcloned into pAMPl (GIBCOBRL) using the CloneAmp system (GIBCOBRL) to create pCGN5522 and the Δ5 desaturase sequence was verified by sequencing of both strands.
For seed-specific expression, the Ma29 coding region was cut out of pCGN5522 as an Xhol fragment and inserted into the Sail site of the napin expression cassette, pCGN3223, to create pCGN5528. The Hindlll fragment of pCGN5528 containing the napin 5' regulatory region, the Ma29 coding region, and the napin 3' regulatory region was inserted into the Hindlll site of pCGN 1557 to create ρCGN5531. Two copies of the napin transcriptional unit were inserted in tandem. This tandem construct can permit higher expression of the desaturases per genetic loci. pCGN55 l was introduced inio Brassica napus cv.LP004 via Agrobacterium mediated transformation. The fatty acid composition of twenty-seed pools of mature T2 seeds was analyzed by GC. Table 2 shows the results obtained with independent transformed Sines as compared to non-transformed LP004 seed The transgenic seeds containing
pCGN5531 contain two fatty acids that arc not present in the control seeds, tentatively identified as taxoleic acid (5,9-18:2) and pinolenic acid (5.9.12- 18:3). based on their elution relative to oleic and linoleic acid. These would be the expected products of Δ5 desaiuration of oleic and linoleic acids. No other differences in fatty acid composition were observed in the transgenic seeds.
Example 4 Production of D5-desaturatβd Fatty Acids in Transgenic Plants
The construction of pCGN5531 (D5-desaturase) and fatty acid composition of T2 seed pools is described in Example 3. This example takes the seeds through one more generation and discusses ways to maximize the D5-desaturated fatty acids.
Example 3 describes the fatty acid composition of T2 seed pools of ρCGN55 1 -transformed B. napus cv. LP004 plants. To investigate the segregation of D5-desaturated fatty acids in the T2 seeds and to identify individual plants to be taken on to subsequent generations, half-seed analysis was done. Seeds were germinated overnight in the dark ai 30 degrees on water-soaked filter paper. The outer cotyledon was excised for GC analysis and the rest of the seedling was planted in soil. Results of some of these analyses are shown in the accompanying Table 3. D5.9-18-.2 accumulated to as high as i2% of the total fatty acids and
D5.9,12-18:3 accumulated to up to 0.77% of the fatty acids. These and other individually selected T2 plants were grown in the greenhouse to produce T3 seed.
Table 2 Composition of T2 Pooled Seed
α>
To maximize the accumulation of D5,9 18:2 in seed oil, th pCGN5531 construct could be introduced into a high oleic acid variety of canoia. A high-oleic variety could be obtained by mutation, so-sυppression, or antisense suppression of the D 12 and D I 5 desaturases or other necessary co-f ctors.
To maximize accumulation of D5.9.I2 18:3 in canoia, the pCGN5S l construct could be introduced into a high linoleic strain of canoia. This could be achieved by crossing pCGN5531 -transformed plants with pCGN5542-(M. alpina Dl 2-desaturase) transformed plants. Alternatively, the DS and Dl 2 desaturases could be combined on one T-DNA for transformation. The transcriptional unit consisting of the napin 5'-regulatory region, the M. alpina Dl 2-desaturase coding region, and the napin :V-regulatory region can be cut out of pCGN5541 (described in CGAB320) as a Notl fragment. Notl/Xbal linkers could be ligated and the resulting fragment inserted intυ the Xbal site of ρCGN5531. The resulting plasmid would contain three napin tr_n_cnptional units containing the Λ . alpina Dl 2 desaturase, and two copies of the napin/ A/, alphm' a D5 desaturase/napin unit, all oriented in the same direction as the 35S/nptII/rml transcriptional unit used for selection of transformed tissue.
Example 5
Expression of M. alpina Δ6 Desaturase in Brassica napus
A nucleic acid sequence from a partial cDNA clone, Ma524, encoding a Δ6 fatty acid desaturase from Mortierella alpina was obtained by random sequencing of clones from the M. alpina cDNA library. The a524 cDNA was modified by PCR to introduce cloning sites using the following primers:
Ma524PCR-l
5'-CUACUACUACUATCTAGACTCGAGACCATGGCTGCTGCT CCAGTGTG
M«*524PCR-2
5 -CAUCAUCAUCAUAGGCCTCGAGTTACTGCGCCTTACCCAT
These primers allowed the amplification of the entire coding region and added Xbal and Xhol sites to the 5 -en and Xhol and Stul sites to the 3' end. The PCR produci was subcloned into pAMPl (GIBCOBRL) using the CloneAmp system (GIBCOBRL) to create pCGN5535 and the Δ6 desaturnse sequence was verified by • equencing of both strands.
For seed-specific expression, the Ma524 coding region was cut out of pCGN5535 as an Xhol fragment and inserted into the Sail site of the napin expression cassette, pCGN3223. to create pCGN5536. The Notl fragment of pCGN5536 containing the napin 5' regulatory region, the Ma524 coding region, and the napin 3' regulatory region was inseπed into the Notl site of pCGN 1557 to create pCGN5538. pCGN5538 was introduced into Brassica napus cv.LP004 via Agrobacterium mediated transformation, Maturing T2 .seeds were collected from 6 independent transformation events in the greenhouse. The fatty acid composition of single seeds was analyzed by GC. Table 4 shows the results of control LP004 seeds and six 5538 lines. All of the 5538 lines except #8 produced seeds containing GLA. Presence of GLA segregated in these seeds as is expected for the T2 selfed swid population. In addition to GLA, the M. alpina Δ6 desatυrase is' apable of producing 18:4
(stearidonic) and another fatly acid believed to be the 6,9- 18:2.
The above results show that desaturases with three different substrate specificities can be expressed in a heterologous system and used to produce polyunsaturated long chain fatty acids. Exemplified were the production of ARA (20:4) from the precursor 20:3 (DGLA), the production of GLA ( 18:3) from 18:2 substrate, and the conversion of 18: 1 substrate to 18:2, which is the precursor for GLA.
Example 6
Production of P6.9 18:2 in Canoia Oil
Example 5 described construction of pCGN5538 designed to express the M. alpina D6 desaturase in seeds of tran.sgenic canoia. Table 4 in thai example showed example, of single seed analyses from 6 independent transgenic events.
Significant amounts of GLA were produced, in addition to the D6,9 18:2 fatty acid.
A total of 29 independent pCGNS538-transformed transgenic plants of the lovf-liπolcnic LP004 culiivar were regenerated and grown in the greenhouse. Table 5 shows the fatty acid composition of 20-seed pools of T2 seed from each event. Seven of the lines contained more than 2% of the D6,9 18:2 in the seed pools. To identify and select plants with high amounts of D6,9 18:2 to be taken υn to subsequent generations, half-seed analysis was done. Seeds were germinated overnight in the dark at 30 degrees, on water-soaked filter paper. The outer cotyledon was excised for GC analysis and the rest of the seedling was planted in soil. Based on results of fatty acid analysis, selected T2 plants were grown in the greenhouse to produce T3 seed. The selection cycle was repeated; pools of T3 seed were analyzed for D6.9 18:2, T3 half-seeds were dissected and analyzed, and selected T3 plants were grown in the greenhouse to produce T4 seed. Pools of T4 se d were analyzed for fatty acid composition. Table 5 summarizes the results of this process for lines derived from one of the original transgenic events, 5538-
LP004-25. Levels of D6,9 18:2 have thus been maintained through 3 generations.
To maximize the amount of D6.9 18:2 that could be produced, the pCGN5538 construct could be introduced into a high oleic acid variety of canoia either by transformation or crossing. A high-oleic variety could be obtained by mutation, co-suppression, or mtiscnse suppression of the D12 and D15 desaturases or other necessary co- factors.
Example 7 Identification of potentially useful Dl5/ω-3 desaturases from other organisms
To look for desaturases involved in PUFA production, cDNA libraries were constructed from total RNA isolated from Schizochytrium (unknown species - proprietary strain supplied by Kelco in San Diego). Plasmid-based cDNA libraries were constructed in pSPORTl (GIBCO-BRL) following manufacturer's instructions using a commercially available kit (GIBCO-BRL). Random cDNA clones were sequenced and nucleic acid sequences that encode putati ve desaturases were identified through BLAST search of the databases and comparison to known
D12 and D1S sequences.
One clone was identified from the Schizochyirium library with homology to both D12 and D15 desaturases; it is called 81-53-A2. The DNA Sequence is presented as Seq ID NO: 1. The corresponding peptide sequence is presented as
SEQ ID NO: 2
SEQUENCE LISTING
( l ) GENERAL INFORMATION:
APPLICANT: KNUTZON. DEBORAH et al .
(ii) TITLE OF INVENTION: POLY-UNSATURATED FATTY ACIDS IN PLANTS
<iii) NUMBER OP SEQUENCES:
(iv) CORRESPONDENCE ADDRESS:
(A) ADDRESSEE: LIMBACH 8t UMBACH L.P.
(B) STREET: 2001 PERRY BUILDING (C) CI TY: SAN FRANCISCO (D) STATE: CA
(E) COUNTRY: USA ] (F) ZIP; *»I 1 I
(v) COMPUTER READABLE FORM: (A) MEDIUM TYPE; Floppy disk
(B) COMPUTER: IBM PC compatible
(C) OPERATING SYSTEM: PC-DOS/MS-DOS <D) SOFTWARE Micru.oή Word
(vi) CURRENT APPLICATION DATA:
(A) APPLICATION NUMBER:
(B) FILING DATE.
(C) CLASSIFICATION:
(vll) PRIOR APPLICATION DATA:
(A) APPLICATION NUMBER: (8) FILING DATE:
(vϋ) PRIOR APPLICATION DATA: (A) APPLICATION NUMBER. US 08/833,610
(8) FILING DATE. 1 1-ΛPR-IW7
(viii) ATTORNEY/AGENT INFORMATION: (A) NAME: MICHAEL R. WARD
(B) REGISTRATION NUMBER: 3B.351
(C) REFERENCE DOCKET NUMBER: CGMO-WO
(ix) TELECOMMUNICATION INFORMATION: (A) TELEPHONE: ( 15) 433-4150 (B) TELEFAX: ( I S) 433-8716 (C) TELEX: N/A
(2) INFORMATION FOR SEQ ID NO: I:
CACGGAAG A AGCCTTGACA TCCTΓ∑'GCCA ACATGTGCAA GGTCGAGACC AΛGCΛGCACG 60
CTSCGβCCAC CGCCGTCCAG GCACCGGAGC AGCA-CACCA GCAOCAGCAG CAGTOGCAGC 120
AGTCGCλCC CCTGCCGTCC GCAGCGCAAC CCTCGGCGGG GGAAGTCCTG GAAAAACGAC ιao
CCATTATCCA TGGCAAGCAC AACCCAGAC TGCCCACGCT CGGAGA6ATT C-CGCCGCOG -40
TGCCCAAGCA CTGCTTCCAC CCCT GCTCC TCACCAGTTC GCT-'fATcrr SGGCGCGACC .00
TC3TCATGGC AACGATCCTG TTCTGCATGG CGCGGCACTT CCTGCCCGTA TACGACΛTGG 360
GC3TCTTC<Ϊ_ CGCCATCGGC TGGACAAGCC TACGTAATTG TTCAAGGGAC AGTCTTTGCT «20
CCACTCTGGG TCCTCGGTCA •fGAGTGCGGA CACCAGGCAT TTTCCAACTA CAGAG AGTC 4Θ0
AΛCGACACCC TCGGCTACCT TGTGCACACT GCCTTGCTl i TGCCTTACTT TAGCTGGGCG SβO
TACACGCATG GCTTGCACCA CGCCCGTGTC AACCACATOC TCGACOGCGA -TCTCACACT 600
CCCAACCTGC AAAAGλAAGT CATGGCTAAC TTTCAAAAOT TAGCCGACCT CATGGGCGAC 660
GA3GCCTTTG CTGTCCTCCA CGTCTTTGTT TATCTCCTCC TTCCCTGGCC SCTGTATATC 720
ΛTCAATGGCA GCGG-CCATC CAAGCGCAAC CΛCGAGGGTA AGCGGTGGTC AAAGCAGATG 780
CTCAλGCGGC -TAACCACTT CTTGCCCACC TCGGAGCTCT CC' GGΛCAA 3ATCCOTCTC 040
AGTGTGGCAG GCTCTACGG CGGT-TCCTC GTCGTCATTG CTAGCTTGTG TTACTGGCiGT 900
TCCATCGAOG GTTCGCCGAt: CGTGCTGCTT CAGTACTTTC TCCCTTACCT TX-TTGΓGAAC 960
GCCTACCTCA TTGGTTTCA ATGGATGCAG CATΛCTCACC AAGATGTCCC 3CATCTTOGC 1020
GAAGACGAAG TGGTCCTGGC TCGCTGGAAC CATTCTCACC ATCCATCGCC TTATCCTGCC 1080
TTTATCGACG TACTCACACA CCGCATCGGA TCCATGCACG TTGCUCATCA TCTTTTCTCG 1140
AAGATGCCCT GGTΛCCATGC CCGC3AAGCC ACTCTTCAOA TCAAGGCTTT 3CTTGAGCCC 1200
ΛA3GGGGTCT ACAACTATGA CCCGACGCCG TTTΛCAΛCGC GCTGTACAAC ACCGCCAGAT 1260
ACTGTCACTT TATGGAGCGC GTCGAAGGCA TTCAGTTCTT CAAACACGTT -ΛCCCTCAAT 1320
CTACAAAAGC AAAGGT CT •ΓAAGATTTCC TCCTTCTAGG AT ATCACTT TCATTCCTAC 1340
CATACAATAT AACTTCATCU CCCCTTCCCG TAATCAATTT. G7CTCTCTTT TC 1392
(C) STRANDEDNESS: tingle
(D) TOPOLOGY: linear
^1-
(ii) MOLECULE TYPE: DNA (genomic)
(2) INFORMATION FOR SEQ ID NO:.;
LMXQKQ SSKISSr
Claims
1. A method of producing a polyunsaturated fatty acid in a host cell comprising the steps of:
(A) transforming a host cell with a nucleotide sequence comprising: 1) an expression cassette comprising a transcriptional and translational initiation regulatory region, said expression cassette being joined in reading frame 5' to 2) a DNA sequence encoding a desaturase polypeptide which modulates the production of polyunsaturated fatty acids; and
(B) culturing said transformed host cell under time and conditions sufficient for the expression of said desaturase polypeptide in said host cell, expression of said desaturase polypeptide resulting in production of polyunsaturated fatty acids by said host cell .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU45643/99A AU4564399A (en) | 1998-06-12 | 1999-06-11 | Polyunsaturated fatty acids in plants |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8914998P | 1998-06-12 | 1998-06-12 | |
US60/089,149 | 1998-06-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999064616A2 true WO1999064616A2 (en) | 1999-12-16 |
WO1999064616A3 WO1999064616A3 (en) | 2000-03-09 |
Family
ID=22215964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/013332 WO1999064616A2 (en) | 1998-06-12 | 1999-06-11 | Polyunsaturated fatty acids in plants |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4564399A (en) |
WO (1) | WO1999064616A2 (en) |
Cited By (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1080189A1 (en) * | 1998-05-29 | 2001-03-07 | Ohio University | Compositions and methods for the synthesis of fatty acids, their derivatives and downstream products |
WO2003064638A2 (en) * | 2002-01-30 | 2003-08-07 | Basf Plant Science Gmbh | Elongase gene and method for producing polyunsaturated fatty acids |
WO2004076617A2 (en) | 2003-02-27 | 2004-09-10 | Basf Plant Science Gmbh | Method for the production of polyunsaturated fatty acids |
EP1527182A2 (en) * | 2002-03-01 | 2005-05-04 | BASF Plant Science GmbH | Process for the production of unsaturated fatty acids |
WO2005059130A1 (en) * | 2003-12-17 | 2005-06-30 | Suntory Limited | Arachidonic acid-containing plant and utilization of the same |
WO2005083053A2 (en) | 2004-02-27 | 2005-09-09 | Basf Plant Science Gmbh | Method for producing unsaturated omega-3 fatty acids in transgenic organisms |
WO2006100241A2 (en) | 2005-03-22 | 2006-09-28 | Basf Plant Science Gmbh | Method for producing polyunsaturated c20 and c22 fatty acids with at least four double bonds in transgenic plants |
EP1718156A2 (en) * | 2004-02-04 | 2006-11-08 | The General Hospital Corporation | Compositions and methods for modifying the content of polyunsaturated fatty acids in biological cells |
EP1726652A2 (en) | 2002-02-27 | 2006-11-29 | Rothamsted Experimental Station | Delta 6-desaturases from primulaceae, expressing plants and PUFA-containing oils |
WO2007017419A2 (en) | 2005-08-09 | 2007-02-15 | Basf Plant Science Gmbh | Method for producing arachidonic acid and/or eicosapentaenoic acid in useful transgenic plants |
WO2007042510A2 (en) | 2005-10-13 | 2007-04-19 | Basf Plant Science Gmbh | Process for the production of arachidonic acid and/or eicosapentaenoic acid |
WO2007051577A2 (en) | 2005-11-02 | 2007-05-10 | Basf Plant Science Gmbh | METHOD FOR THE PRODUCTION OF γ-LINOLENIC ACID AND/OR STEARIDONIC ACID IN TRANSGENIC BRASSICACEAE AND LINACEAE |
US7544859B2 (en) | 2000-02-09 | 2009-06-09 | Basf Aktiengesellschaft | Elongase gene and method for producing multiple-unsaturated fatty acids |
US7601889B2 (en) | 2001-03-26 | 2009-10-13 | Napier Johnathan A | Elongase gene and production of Δ9-polyunsaturated fatty acids |
US7629503B2 (en) | 2003-04-08 | 2009-12-08 | Basf Plant Science Gmbh | Δ-4 desaturases from Euglena gracilis, expressing plants, and oils containing PUFA |
EP2166090A2 (en) | 2003-08-01 | 2010-03-24 | BASF Plant Science GmbH | Method for production of polyunsaturated fatty acids in transgene organisms |
US7700833B2 (en) | 2002-03-01 | 2010-04-20 | Cornell University | Process for the production of unsaturated fatty acids |
EP2177605A1 (en) | 2006-10-06 | 2010-04-21 | BASF Plant Science GmbH | Method for producing polyunsaturated fatty acids in transgenic non-human organisms |
US7714185B2 (en) | 2002-12-19 | 2010-05-11 | University Of Bristol | Method for the production of polyunsaturated fatty acids |
US7807849B2 (en) | 2004-04-22 | 2010-10-05 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US7834250B2 (en) | 2004-04-22 | 2010-11-16 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US7855321B2 (en) | 2003-03-31 | 2010-12-21 | University Of Bristol | Plant acyltransferases specific for long-chained, multiply unsaturated fatty acids |
DE112008003237T5 (en) | 2007-12-14 | 2011-03-17 | Basf Plant Science Gmbh | Promoters of Brassica napus for seed-specific gene expression |
EP2380984A2 (en) | 2006-02-16 | 2011-10-26 | BASF Plant Science GmbH | Nucleic acid |
WO2011161093A1 (en) | 2010-06-25 | 2011-12-29 | Basf Plant Science Company Gmbh | Acyltransferases and uses therof in fatty acid production |
DE112009002048T5 (en) | 2008-08-26 | 2012-01-26 | Basf Plant Science Gmbh | Nucleic acid encoding desaturases and modified plant oil |
DE112009001585T5 (en) | 2008-07-01 | 2012-02-23 | Basf Plant Science Gmbh | Promoters of Brassica napus for seed-specific gene expression |
DE112009003708T5 (en) | 2008-12-12 | 2012-09-13 | Basf Plant Science Gmbh | Desaturases and methods of producing polyunsaturated fatty acids in transgenic organisms |
EP2500420A1 (en) | 2006-08-24 | 2012-09-19 | BASF Plant Science GmbH | Pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains |
US8318914B2 (en) | 2007-07-31 | 2012-11-27 | Bioriginal Food & Science Corp. | Elongases and methods for producing polyunsaturated fatty acids in transgenic organisms |
EP2623584A1 (en) | 2004-02-27 | 2013-08-07 | BASF Plant Science GmbH | Method for producing polyunsatured fatty acids in transgenic plants |
US8785727B2 (en) | 2008-04-30 | 2014-07-22 | Rothamsted Research Ltd. | Desaturase and method for the production of polyunsaturated fatty acids in transgenic organisms |
US8816111B2 (en) | 2012-06-15 | 2014-08-26 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising polyunsaturated fatty acids |
US8835715B1 (en) | 2000-06-30 | 2014-09-16 | Basf Plant Science Gmbh | Plants expressing Δ6-desaturase genes and oils from these plants containing PUFAS and method for producing unsaturated fatty acids |
EP2821492A2 (en) | 2009-05-13 | 2015-01-07 | BASF Plant Science Company GmbH | Acyltransferases and uses thereof in fatty acid production |
US8952217B2 (en) | 2005-10-14 | 2015-02-10 | Metanomics Gmbh | Process for decreasing verbascose in a plant by expression of a chloroplast-targeted fimD protein |
US9718759B2 (en) | 2013-12-18 | 2017-08-01 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising docosapentaenoic acid |
US9938486B2 (en) | 2008-11-18 | 2018-04-10 | Commonwealth Scientific And Industrial Research Organisation | Enzymes and methods for producing omega-3 fatty acids |
US10005713B2 (en) | 2014-06-27 | 2018-06-26 | Commonwealth Scientific And Industrial Research Organisation | Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the sn-2 position |
US10190131B2 (en) | 2006-02-21 | 2019-01-29 | Basf Plant Science Gmbh | Method for producing polyunsaturated fatty acids |
US10513717B2 (en) | 2006-08-29 | 2019-12-24 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of fatty acids |
US10760089B2 (en) | 2014-11-14 | 2020-09-01 | Basf Plant Science Company Gmbh | Materials and methods for increasing the tocopherol content in seed oil |
US11952581B2 (en) | 2003-08-01 | 2024-04-09 | Basf Plant Science Gmbh | Process for the production of polyunsaturated fatty acids in transgenic organisms |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5057419A (en) * | 1988-09-22 | 1991-10-15 | Rutgers University | Genetically engineered plasmid and organisms for the production of specialized oils |
-
1999
- 1999-06-11 WO PCT/US1999/013332 patent/WO1999064616A2/en active Application Filing
- 1999-06-11 AU AU45643/99A patent/AU4564399A/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5057419A (en) * | 1988-09-22 | 1991-10-15 | Rutgers University | Genetically engineered plasmid and organisms for the production of specialized oils |
Non-Patent Citations (2)
Title |
---|
MICHAELSON L ET AL: "Isolation of a delta5-fatty acid desaturase gene from Mortierella alpina" JOURNAL OF BIOLOGICAL CHEMISTRY,US,AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, vol. 30, no. 273, page 19055-19059 XP002076636 ISSN: 0021-9258 * |
SPYCHALLA J ET AL: "Identification of an animal omega-3 fatty acid desaturase by heterologous expression in Arabidopsis" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA,US,NATIONAL ACADEMY OF SCIENCE. WASHINGTON, vol. 4, no. 94, page 1142-1147 XP002076628 ISSN: 0027-8424 * |
Cited By (134)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1080189A4 (en) * | 1998-05-29 | 2003-01-08 | Univ Ohio | Compositions and methods for the synthesis of fatty acids, their derivatives and downstream products |
EP1080189A1 (en) * | 1998-05-29 | 2001-03-07 | Ohio University | Compositions and methods for the synthesis of fatty acids, their derivatives and downstream products |
US9611441B2 (en) | 1999-07-06 | 2017-04-04 | Basf Plant Science Gmbh | Plants expressing Δ6-desaturase genes and oils from these plants containing PUFAS and method for producing unsaturated fatty acids |
US7544859B2 (en) | 2000-02-09 | 2009-06-09 | Basf Aktiengesellschaft | Elongase gene and method for producing multiple-unsaturated fatty acids |
US8933300B2 (en) | 2000-02-09 | 2015-01-13 | Basf Aktiengesellschaft | Elongase gene, and process for the preparation of polyunsaturated fatty acids |
US8835715B1 (en) | 2000-06-30 | 2014-09-16 | Basf Plant Science Gmbh | Plants expressing Δ6-desaturase genes and oils from these plants containing PUFAS and method for producing unsaturated fatty acids |
US7601889B2 (en) | 2001-03-26 | 2009-10-13 | Napier Johnathan A | Elongase gene and production of Δ9-polyunsaturated fatty acids |
AU2003206714B2 (en) * | 2002-01-30 | 2007-09-06 | Basf Plant Science Gmbh | Elongase gene and method for producing polyunsaturated fatty acids |
US7179647B2 (en) | 2002-01-30 | 2007-02-20 | Basf Plant Science Gmbh | Elongase gene and method for producing polyunsaturated fatty acids |
WO2003064638A3 (en) * | 2002-01-30 | 2003-12-31 | Basf Plant Science Gmbh | Elongase gene and method for producing polyunsaturated fatty acids |
WO2003064638A2 (en) * | 2002-01-30 | 2003-08-07 | Basf Plant Science Gmbh | Elongase gene and method for producing polyunsaturated fatty acids |
EP1726652A2 (en) | 2002-02-27 | 2006-11-29 | Rothamsted Experimental Station | Delta 6-desaturases from primulaceae, expressing plants and PUFA-containing oils |
EP1527182A2 (en) * | 2002-03-01 | 2005-05-04 | BASF Plant Science GmbH | Process for the production of unsaturated fatty acids |
EP1527182A4 (en) * | 2002-03-01 | 2005-12-21 | Basf Plant Science Gmbh | Process for the production of unsaturated fatty acids |
US7700833B2 (en) | 2002-03-01 | 2010-04-20 | Cornell University | Process for the production of unsaturated fatty acids |
US7714185B2 (en) | 2002-12-19 | 2010-05-11 | University Of Bristol | Method for the production of polyunsaturated fatty acids |
US7537920B2 (en) | 2003-02-27 | 2009-05-26 | Basf Plant Science Gmbh | Method for the production of polyunsaturated fatty acids |
US8486671B2 (en) | 2003-02-27 | 2013-07-16 | Basf Plant Science Gmbh | Method for the production of polyunsaturated fatty acids |
WO2004076617A2 (en) | 2003-02-27 | 2004-09-10 | Basf Plant Science Gmbh | Method for the production of polyunsaturated fatty acids |
US7855321B2 (en) | 2003-03-31 | 2010-12-21 | University Of Bristol | Plant acyltransferases specific for long-chained, multiply unsaturated fatty acids |
EP2365063A1 (en) | 2003-03-31 | 2011-09-14 | University Of Bristol | New vegetable acyltransferases specifically for long-chain polyunsaturated fatty acids |
EP2390313A1 (en) | 2003-03-31 | 2011-11-30 | University Of Bristol | New vegetable acyltransferases specifically for long-chain polyunsaturated fatty acids |
US8354569B2 (en) | 2003-03-31 | 2013-01-15 | University Of Bristol | Plant acyltransferases specific for long-chained, multiply unsaturated fatty acids |
US7629503B2 (en) | 2003-04-08 | 2009-12-08 | Basf Plant Science Gmbh | Δ-4 desaturases from Euglena gracilis, expressing plants, and oils containing PUFA |
EP2166089A2 (en) | 2003-08-01 | 2010-03-24 | BASF Plant Science GmbH | Method for production of polyunsaturated fatty acids in transgenic organisms |
US9433228B2 (en) | 2003-08-01 | 2016-09-06 | Basf Plant Science Gmbh | Method for the production of multiple-unsaturated fatty acids in transgenic organisms |
EP2166069A2 (en) | 2003-08-01 | 2010-03-24 | BASF Plant Science GmbH | Method for producing polyunsaturated fatty acids in transgenic organisms |
EP2166071A2 (en) | 2003-08-01 | 2010-03-24 | BASF Plant Science GmbH | Method for producing polyunsaturated fatty acids in transgenic organisms |
EP2169053A2 (en) | 2003-08-01 | 2010-03-31 | BASF Plant Science GmbH | Method for production of polyunsaturated fatty acids in transgenic organisms |
EP2169052A2 (en) | 2003-08-01 | 2010-03-31 | BASF Plant Science GmbH | Method for production of polyunsaturated fatty acids in transgenic organisms |
EP2172536A2 (en) | 2003-08-01 | 2010-04-07 | BASF Plant Science GmbH | Method for producing polyunsaturated fatty acids in transgenic organisms |
EP2166070A2 (en) | 2003-08-01 | 2010-03-24 | BASF Plant Science GmbH | Method for producing polyunsaturated fatty acids in transgenic organisms |
EP2166090A2 (en) | 2003-08-01 | 2010-03-24 | BASF Plant Science GmbH | Method for production of polyunsaturated fatty acids in transgene organisms |
US11952581B2 (en) | 2003-08-01 | 2024-04-09 | Basf Plant Science Gmbh | Process for the production of polyunsaturated fatty acids in transgenic organisms |
US11180769B2 (en) | 2003-08-01 | 2021-11-23 | Basf Plant Science Gmbh | Method for the production of multiple-unsaturated fatty acids in transgenic organisms |
EP3395945A1 (en) | 2003-08-01 | 2018-10-31 | BASF Plant Science GmbH | Method for producing polyunsatured fatty acids in transgenic organisms |
KR101152423B1 (en) | 2003-12-17 | 2012-06-05 | 산토리 홀딩스 가부시키가이샤 | Arachidonic acid-containing plant and utilization of the same |
US7943816B2 (en) * | 2003-12-17 | 2011-05-17 | Suntory Holdings Limited | Arachidonic acid-containing plants and use of the plants |
WO2005059130A1 (en) * | 2003-12-17 | 2005-06-30 | Suntory Limited | Arachidonic acid-containing plant and utilization of the same |
CN1894405B (en) * | 2003-12-17 | 2011-02-02 | 三得利控股株式会社 | Arachidonic acid-containing plant and utilization of the same |
AU2004298565B2 (en) * | 2003-12-17 | 2009-06-04 | Suntory Holdings Limited | Arachidonic acid-containing plant and utilization of the same |
EP1718156A4 (en) * | 2004-02-04 | 2008-12-10 | Gen Hospital Corp | Compositions and methods for modifying the content of polyunsaturated fatty acids in biological cells |
EP1718156A2 (en) * | 2004-02-04 | 2006-11-08 | The General Hospital Corporation | Compositions and methods for modifying the content of polyunsaturated fatty acids in biological cells |
US7777098B2 (en) | 2004-02-27 | 2010-08-17 | Basf Plant Science Gmbh | Method for producing unsaturated ω-3-fatty acids in transgenic organisms |
US9458436B2 (en) | 2004-02-27 | 2016-10-04 | Basf Plant Science Gmbh | Method for producing polyunsaturated fatty acids in transgenic plants |
EP2623584A1 (en) | 2004-02-27 | 2013-08-07 | BASF Plant Science GmbH | Method for producing polyunsatured fatty acids in transgenic plants |
US9624477B2 (en) | 2004-02-27 | 2017-04-18 | Basf Plant Science Gmbh | Method for producing unsaturated omega-3-fatty acids in transgenic organisms |
US8373024B2 (en) | 2004-02-27 | 2013-02-12 | Basf Plant Science Gmbh | Method for producing unsaturated ω-3-fatty acids in transgenic organisms |
WO2005083053A2 (en) | 2004-02-27 | 2005-09-09 | Basf Plant Science Gmbh | Method for producing unsaturated omega-3 fatty acids in transgenic organisms |
US10035989B2 (en) | 2004-02-27 | 2018-07-31 | Basf Plant Science Gmbh | Method for producing polyunsaturated fatty acids in transgenic plants |
US9994880B2 (en) | 2004-04-22 | 2018-06-12 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cell |
US7807849B2 (en) | 2004-04-22 | 2010-10-05 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US8106226B2 (en) | 2004-04-22 | 2012-01-31 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US9970033B2 (en) | 2004-04-22 | 2018-05-15 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cell |
US9963723B2 (en) | 2004-04-22 | 2018-05-08 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US8158392B1 (en) | 2004-04-22 | 2012-04-17 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US9951357B2 (en) | 2004-04-22 | 2018-04-24 | Commonweatlh Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cell |
US9926579B2 (en) | 2004-04-22 | 2018-03-27 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cell |
US10443079B2 (en) | 2004-04-22 | 2019-10-15 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cell |
US11597953B2 (en) | 2004-04-22 | 2023-03-07 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US7834250B2 (en) | 2004-04-22 | 2010-11-16 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US9458410B2 (en) | 2004-04-22 | 2016-10-04 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cell |
US9453183B2 (en) | 2004-04-22 | 2016-09-27 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cell |
US8071341B2 (en) | 2004-04-22 | 2011-12-06 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US10781463B2 (en) | 2004-04-22 | 2020-09-22 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US7932438B2 (en) | 2004-04-22 | 2011-04-26 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US11220698B2 (en) | 2004-04-22 | 2022-01-11 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
US8049064B2 (en) | 2005-03-22 | 2011-11-01 | Basf Plant Science Gmbh | Method for producing polyunsaturated C20- and C22-fatty acids with at least four double bonds in transgenic plants |
WO2006100241A2 (en) | 2005-03-22 | 2006-09-28 | Basf Plant Science Gmbh | Method for producing polyunsaturated c20 and c22 fatty acids with at least four double bonds in transgenic plants |
WO2007017419A2 (en) | 2005-08-09 | 2007-02-15 | Basf Plant Science Gmbh | Method for producing arachidonic acid and/or eicosapentaenoic acid in useful transgenic plants |
US8134046B2 (en) | 2005-08-09 | 2012-03-13 | Basf Plant Science Gmbh | Method for producing arachidonic acid and/or eicosapentaenoic acid in useful transgenic plants |
WO2007042510A2 (en) | 2005-10-13 | 2007-04-19 | Basf Plant Science Gmbh | Process for the production of arachidonic acid and/or eicosapentaenoic acid |
US8273958B2 (en) | 2005-10-13 | 2012-09-25 | Basf Plant Science Gmbh | Process for the production of arachidonic acid and/or eicosapentaenoic acid |
US8017839B2 (en) | 2005-10-13 | 2011-09-13 | Basf Plant Science Gmbh | Process for the production of arachidonic acid and/or eicosapentaenoic acid |
US8258371B2 (en) | 2005-10-13 | 2012-09-04 | Basf Plant Science Gmbh | Process for the production of arachidonic acid and/or eicosapentaenoic acid |
EP2450434A2 (en) | 2005-10-13 | 2012-05-09 | BASF Plant Science GmbH | Process for the production of arachidonic acid and/or eicosapentaenoic acid |
US8952217B2 (en) | 2005-10-14 | 2015-02-10 | Metanomics Gmbh | Process for decreasing verbascose in a plant by expression of a chloroplast-targeted fimD protein |
US8013216B2 (en) | 2005-11-02 | 2011-09-06 | Basf Plant Science Gmbh | Method for the production of γ-linolenic acid and/or stearidonic acid in transgenic Brassicaceae and Linaceae |
WO2007051577A2 (en) | 2005-11-02 | 2007-05-10 | Basf Plant Science Gmbh | METHOD FOR THE PRODUCTION OF γ-LINOLENIC ACID AND/OR STEARIDONIC ACID IN TRANSGENIC BRASSICACEAE AND LINACEAE |
EP2380984A2 (en) | 2006-02-16 | 2011-10-26 | BASF Plant Science GmbH | Nucleic acid |
US10301638B2 (en) | 2006-02-21 | 2019-05-28 | Basf Plant Science Gmbh | Oils, lipids and fatty acids produced in transgenic Brassica plant |
US10533182B2 (en) | 2006-02-21 | 2020-01-14 | Basf Plant Science Gmbh | Oils, lipids and fatty acids produced in transgenic brassica plant |
US10533183B2 (en) | 2006-02-21 | 2020-01-14 | Basf Plant Science Gmbh | Oils, lipids and fatty acids produced in transgenic Brassica plant |
US10190131B2 (en) | 2006-02-21 | 2019-01-29 | Basf Plant Science Gmbh | Method for producing polyunsaturated fatty acids |
EP2500420A1 (en) | 2006-08-24 | 2012-09-19 | BASF Plant Science GmbH | Pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains |
US9029111B2 (en) | 2006-08-24 | 2015-05-12 | Basf Plant Science Gmbh | Isolation and characterization of a novel pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains |
US10113189B2 (en) | 2006-08-24 | 2018-10-30 | Basf Plant Science Gmbh | Isolation and characterization of a novel pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains |
US10513717B2 (en) | 2006-08-29 | 2019-12-24 | Commonwealth Scientific And Industrial Research Organisation | Synthesis of fatty acids |
US9382529B2 (en) | 2006-10-06 | 2016-07-05 | Basf Plant Science Gmbh | Processes for producing polyunsaturated fatty acids in transgenic organisms |
US11168308B2 (en) | 2006-10-06 | 2021-11-09 | Basf Plant Science Gmbh | Processes for producing polyunsaturated fatty acids in transgenic organisms |
EP2182056A1 (en) | 2006-10-06 | 2010-05-05 | BASF Plant Science GmbH | Method for producing polyunsaturated fatty acids in transgenic non-human organisms |
US10308914B2 (en) | 2006-10-06 | 2019-06-04 | Basf Plant Science Gmbh | Processes for producing polyunsaturated fatty acids in transgenic organisms |
EP2177605A1 (en) | 2006-10-06 | 2010-04-21 | BASF Plant Science GmbH | Method for producing polyunsaturated fatty acids in transgenic non-human organisms |
US8710299B2 (en) | 2006-10-06 | 2014-04-29 | Basf Plant Science Gmbh | Processes for producing polyunsaturated fatty acids in transgenic organisms |
US8318914B2 (en) | 2007-07-31 | 2012-11-27 | Bioriginal Food & Science Corp. | Elongases and methods for producing polyunsaturated fatty acids in transgenic organisms |
DE112008003237T5 (en) | 2007-12-14 | 2011-03-17 | Basf Plant Science Gmbh | Promoters of Brassica napus for seed-specific gene expression |
US8785727B2 (en) | 2008-04-30 | 2014-07-22 | Rothamsted Research Ltd. | Desaturase and method for the production of polyunsaturated fatty acids in transgenic organisms |
EP2826864A2 (en) | 2008-07-01 | 2015-01-21 | BASF Plant Science GmbH | Promoters from Brassica napus for seed specific gene expression |
DE112009001585T5 (en) | 2008-07-01 | 2012-02-23 | Basf Plant Science Gmbh | Promoters of Brassica napus for seed-specific gene expression |
DE112009002048T5 (en) | 2008-08-26 | 2012-01-26 | Basf Plant Science Gmbh | Nucleic acid encoding desaturases and modified plant oil |
US9938486B2 (en) | 2008-11-18 | 2018-04-10 | Commonwealth Scientific And Industrial Research Organisation | Enzymes and methods for producing omega-3 fatty acids |
US8822662B2 (en) | 2008-12-12 | 2014-09-02 | Basf Plant Science Company Gmbh | Desaturases and process for the production of polyunsaturated fatty acids in transgenic organisms |
DE112009003708T5 (en) | 2008-12-12 | 2012-09-13 | Basf Plant Science Gmbh | Desaturases and methods of producing polyunsaturated fatty acids in transgenic organisms |
US9139854B2 (en) | 2008-12-12 | 2015-09-22 | Basf Plant Science Company Gmbh | Desaturases and process for the production of polyunsaturated fatty acids in transgenic organisms |
EP2669380A1 (en) | 2008-12-12 | 2013-12-04 | BASF Plant Science GmbH | Desaturases and process for the production of polyunsaturated fatty acids in transgenic organisms |
US9828589B2 (en) | 2009-05-13 | 2017-11-28 | Basf Plant Science Company Gmbh | Acyltransferases and uses thereof in fatty acid production |
EP2821492A2 (en) | 2009-05-13 | 2015-01-07 | BASF Plant Science Company GmbH | Acyltransferases and uses thereof in fatty acid production |
US9212371B2 (en) | 2009-05-13 | 2015-12-15 | Basf Plant Science Company Gmbh | Acyltransferases and uses thereof in fatty acid production |
WO2011161093A1 (en) | 2010-06-25 | 2011-12-29 | Basf Plant Science Company Gmbh | Acyltransferases and uses therof in fatty acid production |
US8816111B2 (en) | 2012-06-15 | 2014-08-26 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising polyunsaturated fatty acids |
US8946460B2 (en) | 2012-06-15 | 2015-02-03 | Commonwealth Scientific And Industrial Research Organisation | Process for producing polyunsaturated fatty acids in an esterified form |
US10335386B2 (en) | 2012-06-15 | 2019-07-02 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising polyunsaturated fatty acids |
US9556102B2 (en) | 2012-06-15 | 2017-01-31 | Commonwealth Scientific And Industrial Research Organisation | Process for producing ethyl esters of polyunsaturated fatty acids |
US9550718B2 (en) | 2012-06-15 | 2017-01-24 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising polyunsaturated fatty acids |
US9932289B2 (en) | 2012-06-15 | 2018-04-03 | Commonwealth Scientific And Industrial Research Ogranisation | Process for producing ethyl esters of polyunsaturated fatty acids |
US9725399B2 (en) | 2013-12-18 | 2017-08-08 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising long chain polyunsaturated fatty acids |
US10800729B2 (en) | 2013-12-18 | 2020-10-13 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising long chain polyunsaturated fatty acids |
US11623911B2 (en) | 2013-12-18 | 2023-04-11 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising docosapentaenoic acid |
US9718759B2 (en) | 2013-12-18 | 2017-08-01 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising docosapentaenoic acid |
US10190073B2 (en) | 2013-12-18 | 2019-01-29 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising long chain polyunsaturated fatty acids |
US10125084B2 (en) | 2013-12-18 | 2018-11-13 | Commonwealth Scientific And Industrial Research Organisation | Lipid comprising docosapentaenoic acid |
US10793507B2 (en) | 2014-06-27 | 2020-10-06 | Commonwealth Scientific And Industrial Research Organisation | Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the SN-2 position |
US10005713B2 (en) | 2014-06-27 | 2018-06-26 | Commonwealth Scientific And Industrial Research Organisation | Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the sn-2 position |
US10829775B2 (en) | 2014-11-14 | 2020-11-10 | Basf Plant Science Company Gmbh | Materials and methods for increasing the tocopherol content in seed oil |
AU2015344993C9 (en) * | 2014-11-14 | 2021-08-26 | Basf Plant Science Company Gmbh | Materials and methods for PUFA production, and PUFA-containing compositions |
AU2015344993C1 (en) * | 2014-11-14 | 2021-07-22 | Basf Plant Science Company Gmbh | Materials and methods for PUFA production, and PUFA-containing compositions |
US11260095B2 (en) | 2014-11-14 | 2022-03-01 | Basf Plant Science Company Gmbh | Modification of plant lipids containing PUFAs |
US11484560B2 (en) | 2014-11-14 | 2022-11-01 | Basf Plant Science Company Gmbh | Stabilising fatty acid compositions |
US11033593B2 (en) | 2014-11-14 | 2021-06-15 | Basf Plant Science Company Gmbh | Brassica events LBFLFK and LBFDAU and methods for detection thereof |
US11613761B1 (en) | 2014-11-14 | 2023-03-28 | Bioriginal Food & Science Corporation | Materials and methods for PUFA production, and PUFA-containing compositions |
AU2015344993B2 (en) * | 2014-11-14 | 2021-03-25 | Basf Plant Science Company Gmbh | Materials and methods for PUFA production, and PUFA-containing compositions |
US11771728B2 (en) | 2014-11-14 | 2023-10-03 | Basf Plant Science Company Gmbh | Materials and methods for increasing the tocopherol content in seed oil |
US11813302B2 (en) | 2014-11-14 | 2023-11-14 | Basf Plant Science Company Gmbh | Brassica events LBFLFK and LBFDAU and methods for detection thereof |
US10760089B2 (en) | 2014-11-14 | 2020-09-01 | Basf Plant Science Company Gmbh | Materials and methods for increasing the tocopherol content in seed oil |
Also Published As
Publication number | Publication date |
---|---|
AU4564399A (en) | 1999-12-30 |
WO1999064616A3 (en) | 2000-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2816116B1 (en) | Polyunsaturated fatty acids in plants | |
WO1999064616A2 (en) | Polyunsaturated fatty acids in plants | |
US10174297B2 (en) | Fatty acid desaturases from primula | |
US6075183A (en) | Methods and compositions for synthesis of long chain poly-unsaturated fatty acids in plants | |
US6051754A (en) | Methods and compositions for synthesis of long chain poly-unsaturated fatty acids in plants | |
Robert et al. | Metabolic engineering of Arabidopsis to produce nutritionally important DHA in seed oil | |
ES2525212T3 (en) | Novel procedure for the production of polyunsaturated fatty acids | |
EP2902021B1 (en) | Expression of fatty acid desaturases in corn | |
JP2019068806A (en) | Production of dha and other lc pufas in plants | |
JP2002510205A (en) | Production of polyunsaturated fatty acids by expressing polyketide-like synthetic genes in plants | |
EP0996732A1 (en) | Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants | |
MXPA00012323A (en) | Polyunsaturated fatty acids in plants | |
Napier | Delta 6-desaturases From Primulaceae, Expressing Plants And Pufa-containing Oils (Patent WO 2003/072784 A1) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU BG BR CA CN CZ HU IL JP KR MX NO NZ PL RO SI SK TR |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU BG BR CA CN CZ HU IL JP KR MX NO NZ PL RO SI SK TR |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
122 | Ep: pct application non-entry in european phase |